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The central aim of this thesis is to determine the effectiveness and cost-
effectiveness of a nurse-led psychological intervention for patients with 
mental health problems who visit the general practitioner (GP). 
This first chapter briefly introduces the problems in mental health care for 
GPs and the history of the intervention, the aims and structure of this thesis, 
and objectives are stated. 
To clarify the situation of patients with mental health problems, we start 
with a case vignette.
Case vignette
Adrian is 42-years-old, married, and has two children (12 and 14 years-old). A year 
ago the family moved to a new town where he visited a new GP for the first time. 
Adrian is a youth worker experiencing serious problems at work; being unable to 
cope with pupils and colleagues and very afraid of making mistakes. At home, his 
marital relationship is also not good, and he feels that he does everything wrong. 
Adrian and his wife never do anything nice together, he cannot bring himself to 
enjoy other activities, and feels worried all of the time. When the GP asked him 
what the matter was, he said that he felt tired and down, had a pain in his back, 
and was unable to concentrate. 
Primary mental health care
Patients with problems like Adrian’s are common in general practice. 
The estimated prevalence of psychological disorders varies, but it can be 
safely stated that patients with these kinds of problems visit their general 
practitioner frequently (1). 
Therefore, mental health care is a core activity of primary care (2). The 
GP has become the gate-keeper for not just physical, but also psychological 
care, which frequently means a complicated and substantially expanded 
workload (3;4). Patients with mental health problems have significant 
social impairment, especially when they suffer from affective disorders (5). 
The GP uses guidelines for treatment of both the diagnosis anxiety and 
depression, which have been provided by the Dutch College of General 
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Practitioners (NHG, (6;7)). We will describe these guidelines for depression 
and anxiety shortly.
Depression treatment guidelines for primary care
After depression has been diagnosed, the first step in treating a patient is to explore 
the existence of potential co-morbid disorders and their treatment, provide 
psycho-education concerning depression, and advice regarding lifestyle. 
The GP and patient decide upon the best treatment option, either: by the GP, 
psychological treatment in primary care, or psychotherapy in an outpatient 
clinic. Treatment by the GP comprises one visit every two weeks where daily 
goals are created and pleasurable activities advised. Additional drug treatment 
is also an option, which fits well in daily practice, is acceptable to patients and 
is common (of all patients suffering of depression, only 4% are referred to a 
psychiatrist, psychologist or outpatient clinic) (3). If depression lasts for less than 
three months, no other specific interventions are advised in case of spontaneous 
recovery. In patients who show symptoms after three months, antidepressant 
drug treatment and/ or short-term psychotherapy are advised.
Anxiety treatment guidelines for primary care
After an anxiety disorder is diagnosed, the first step in treating a patient 
is to make an inventory of possible psychosocial stressors and use of 
psychotropic substances related to anxiety. The GP and patient decide upon 
the best treatment option: treatment by the GP (with or without the use 
of sedatives), psychological treatment in primary care, or psychotherapy in 
an outpatient clinic. Cognitive behavioural therapy (CBT) is the evidence-
based treatment for anxiety disorders. Treatment by the GP comprises one 
patient visit every two weeks where psycho-education is given on the role 
of catastrophic cognitions, and avoidance behaviour in the maintenance of 
anxiety symptoms. Drug prescription fits most easily in routine practice, but 
patients often prefer psychotherapy to antidepressants (8). 
Mental health problems in primary care
Unfortunately, treatment tailored to patients with mental health problems is 
not available in general practice. The effectiveness of medication in primary 
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care has been found to have only limited success, with side-effects and non-
compliance increasingly reported over time (9). Referral to a psychiatric 
outpatient clinic involves a waiting list and is not necessary for every mental 
health problem, while, for example, guided self-help could also be effective 
(10). For GPs to advise patients effectively on how to deal with mental health 
problems, better tools and support in daily practice is urgently required. Nurses 
already support some practices and carry out specific tasks. For example, 
diabetes nurses have become quite common in the Netherlands (11) unlike 
mental health nurses (12). When mental health nurses are present in general 
practice, they mostly assess the need for referral or provide short psychological 
treatment or counselling (13). This is in contrast with outpatient mental 
health care, where evidence-based therapies for depression and anxiety are 
widely applied (14).   
Specialized and integrated assistance by mental health nurses could solve this 
problem. Nurses could specialize in short and effective treatment for common 
mental health problems to prevent or stimulate a referral to secondary care 
for patients with complaints, which cannot be treated in primary care. This 
would also stimulate better tailored collaborative forms of care and reduce 
the number of complaints (15). Such treatment has been available as a 
multipurpose stand-alone psychological intervention since 1996, developed 
for particular use in primary care and is called Problem Solving Treatment. 
Problem Solving Treatment 
In 1971 D’Zurilla and Goldfried published a theory in which problem-solving 
was defined as a cyclic process in five stages: problem orientation; problem 
definition; generation of alternative solutions; decision making, and solution 
implementation – collectively called problem solving therapy (16). This therapy 
is strictly protocolized and based on the principles of CBT. 
Problem solving therapy has been applied to a wide range of psychological 
disorders in many areas. For example, the outcome of a meta-analysis showed 
such therapy to be suitable for deliberate self-harm patients (17). Therapy has 
also proven itself in: long-term weight reduction for people suffering from 
obesity (18); in reducing rates of depression, hopelessness and suicidal ideation 
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in patients after a suicide-attempt (19); strengthen problem-solving abilities 
and assertiveness in mildly mentally retarded people (20), palliative care (20); 
diabetes care (21), and elderly people suffering from depression (22).
In 1995 Gath and Mynors-Wallis conducted an experiment using a basic 
form of problem solving called Problem Solving Treatment (PST), developed 
primarily for use in busy and time-constrained primary care settings. It has 
also been developed so that non-mental health specialists (such as nurses) 
in primary care settings can be trained to administer treatment. PST is brief 
when compared to psychotherapy; a maximum of six sessions is advised 
(totalling 3.5 hours). 
PST begins by establishing the link between the symptoms and the practical 
problems that patients experience. The theoretical assumption is that mental 
health problems are often caused by practical problems people experience in 
their everyday lives. Treatment is focused on the ‘here and now’ and setting 
goals for the future (it does not dwell on past relationships and mistakes). PST 
is collaborative, with the patient playing an active part in the recovery process. 
Each session contains seven problem-solving stages applied systematically 
towards problem resolution (Figure 1). Therapy also aims to train patients to 
use problem-solving techniques to overcome their problems themselves, and 
therefore helps them regain a sense of control of their lives (23). 
What do we know about PST?
The following six trials, conducted since 1995, emphasise what was known 
about the effectiveness of PST towards several diagnoses, prior to this trial.
Major depression
In 1995 a PST trial on patients suffering from major depression, consisted 
of three groups. In one group patients received PST from the GP or 
psychiatrist, in another patients received usual care (UC) with amitriptyline 
(an antidepressant), while the third group received a drug placebo. The 
results showed that PST given by the GP or psychiatrist was as effective as 
amitriptyline, in contrast to the drug placebo (24). In this study GPs referred 
patients into the trial, which means patients could be judged as patients who 
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may benefit of the PST by the GP. Although this could be a resemblance of 
daily care, patient selection could not be excluded. While the results show 
an optimistic outcome for PST, the sample size is small; only (around) 30 
patients per group. Therefore, conclusions should be drawn carefully.
In 2000, a second trial for primary care patients suffering from major 
depression was conducted. The patients were recruited from lists of GPs so 
the risk of patient selection is smaller than when referral is done by a GP. 
It was a randomised clinical trial (RCT) with four groups: paroxetine (an 
antidepressant) provided by the GP; PST provided by the GP; PST provided by 
a nurse, and patients who received PST from a nurse and paroxetine provided 
by the GP. No differences in outcomes were found between the groups, and 
the anti-depressant was found to be as effective as PST. Paroxetine combined 
with PST showed no difference with paroxetine or PST alone. Although 116 
patients completed the full course of treatment, the groups were small again 
(around 30) (25). This trial also showed nurses can effectively provide PST.
Minor depression and dysthymia
The third trial discussed here was conducted in 2001 and carried out by 
psychiatrists and PhD psychologists for patients suffering from minor 
depression or dysthymia – randomised in a PST (PhD psychologist), 
paroxetine or placebo condition (psychiatrist). A research psychiatrist judged 
diagnoses for all settings. Patients were recruited from two primary care 
settings (in different countries) for this study, as a part of a larger study for 
comparing results for patients of 60 years and older were four other settings 
were involved.
For dysthymia, paroxetine followed by PST improved remission when 
compared to placebo plus non clinical management. For minor depression, 
the interventions were equally effective; this means for minor depression 
watchful waiting is an appropriate treatment option. PST also proved a good 
option when the severity of symptoms increases (26). In this trial, the groups 
of patients who completed the trial were between 60 to 70 patients. 
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Mental health problems
The fourth study was concerned with patients with mental health problems 
including: anxiety; tension; depressed moods; irritability, and sleep 
disturbance and carried out in 1991. One group of patients was randomised 
in a PST condition, the second group received UC. After 28 weeks the PST 
group showed significantly better results than the UC group, in contrast to 
the post-treatment findings, where no significant differences were found 
(27). In this study, the GPs selected the potentially suitable patients but gave 
them treatment for four weeks, and after these four weeks, patients were 
assessed for participation in the trial. Referrals were made by 26 GPs from 
different practices, 113 patients entered the study, 47 were allocated to PST 
or control condition and 44 patients completed it. The distribution of the 
patients is not clear and the power of this study was not calculated. More 
research is needed to establish this outcome.
The following study was carried out in 1997 and also with patients suffering 
from emotional disorders. The GPs referred the patients to the trial and 
patients were randomly allocated into the separate conditions. Nurses carried 
out PST and the GP provided UC. No differences were found between the 
groups, except for reduced sickness-related days for patients who received 
PST. Seventy patients were allocated, 58 patients completed the trial (28). In 
this study there are small sample sizes (22 PST vs. 36 UC); caution is needed 
to draw any conclusions.
The final trial discussed here is from 2001 and involved three groups. In 62 
practices, 98 GPs referred 247 patients. The patients were randomly allocated 
into the three arms. In one group PST was carried out by psychiatric nurses, in 
another psychiatric nurses delivered UC, while in the third patients received 
UC by the GP. No differences in outcomes were found between the groups, 
although PST patients were more satisfied with the treatment. 173 patients 
completed this trial. The dropout rate was a bit higher in the GP group. 
(29). 
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Overall, it can safely be stated that PST given by nurses, psychiatrists or GPs 
is as good as UC provided by the GP, or in cases of depression, just as good 
as antidepressants. 
PST provided by nurses
Patients with mental health problems need more time than is available in 
general practice. The usual 10-minute consultation with a GP is generally 
too short to explain and explore such problems. Mental disorders are often 
interwoven with physical issues such as fatigue and sleeplessness; and so 
recognising and diagnosing a mental health problem can be difficult. 
Furthermore, patients are often ambiguous when presenting symptoms (30). 
These facts, together with the high prevalence of psychological problems in 
primary care, make it clear that such care needs assistance in treating mental 
health problems. Nurses who are skilled in working with psychiatric patients 
could become indispensable in primary care (13). 
Previous research has shown that nurses can successfully provide effective 
treatment for primary care patients (31). PST is also suitable for non-mental 
health workers, and can also be provided by nurse practitioners or other 
primary care workers. At present, there are still very few nurses working in 
Dutch general practice, and although preliminary experiments are taking 
place to enhance and define the role of nurses in primary care, PST could be 
a welcome innovation in their work profiles. 
Aim and outline of this thesis
The central aim of this study is to investigate whether PST for mental health 
problems provided by nurses in primary care is effective and cost-effective in 
potentially providing GPs and patients with tailored care. 
A randomised clinical trial (RCT) was conducted and analysed over nine 
months. Subsequently, predictors of outcome in the research population were 
studied. Furthermore, the sensitivity of change of two of the questionnaires 
used for primary and secondary outcome analysis was measured.
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The thesis is structured as follows:
In Chapter 2 the protocol of this study is extensively described, including all 
measurements, the design, power calculation and randomisation.
Chapters 3 and 4 present the effectiveness of PST compared to UC at post-
treatment (six months) and follow-up (nine-months). 
In Chapter 4 the predictors of improvement of mental health are also 
described and the analysis and outcome of this analysis is presented and 
discussed.
Chapter 5 is concerned with how well the questionnaires measured the 
sensitivity of change in the trial. We compared an expert-derived questionnaire 
with a patient-generated measurement by comparing effect-sizes and classify 
the problems into a widely used classification system.
Chapter 6 reports on cost-effectiveness of PST compared to usual care.
In Chapter 7 the main findings are summarized, strengths and limitations 
discussed. Recommendations for future research and for general practice are 
presented.
This thesis will be concluded with a summary in English and Dutch.
Translated questionnaires are included in the APPENDIX.
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Abstract
Background
There is a need for assistance from primary care mental health workers in 
general practice in the Netherlands. General practitioners (GPs) experience 
an overload of frequent attenders suffering from psychological problems. 
Problem Solving Treatment (PST) is a brief psychological treatment tailored 
for use in a primary care setting. PST is provided by nurses, and earlier 
research has shown that it is a treatment at least as effective as usual care. 
However, research outcomes are not totally satisfying. This protocol describes 
a randomised clinical trial on the effectiveness of PST provided by nurses for 
patients in general practice. The results of this study, which currently being 
carried out, will be presented as soon as they are available.
Methods/design
This study protocol describes the design of a randomised controlled trial 
to investigate the effectiveness and cost-effectiveness of PST and usual care 
compared to usual care only.
Patients, 18 years and older, who present psychological problems and are 
frequent attenders in general practice are recruited by the research assistant. 
The participants receive questionnaires at baseline, after the intervention, 
and again after 3 months and 9 months. Primary outcome is the reduction 
of symptoms, and other outcomes measured are improvement in problem 
solving skills, psychological and physical well being, daily functioning, social 
support, coping styles, problem evaluation and health care utilization.
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background
In primary care the prevalence of psychological problems (e.g. depression, 
anxiety, stress, somatization, unexplained or functional symptoms) ranges 
from 30% to 70%. Patients with these complaints, symptoms or disorders 
frequently visit their general practitioner (1) and only 3% of all patients 
are referred to a specialist. This implies that mental health care is a core 
activity in primary care (2). For many of these complaints and symptoms no 
evidence-based treatment is available(3). There is a clear need for an effective 
treatment for common mental disorders in primary care.
Problem Solving Treatment (PST) in primary care
In 1971 D’Zurilla and Goldfried published a theory in which problem solving 
was defined as a cyclic process in five stages: problem orientation; problem 
definition; generation of alternative solutions; decision making, and solution 
implementation and was called problem solving therapy (4). Since then, 
problem solving therapy has been applied for a wide range of psychological 
problems in all kinds of areas. In 1995 Gath and Mynors-Wallis conducted 
an experiment based on a basic form of PST in primary care. This is strictly 
protocollized and based on the principles of cognitive behavioural therapy 
(CBT) (5). The treatment is brief and focuses on practical skill-building. 
It consists of a maximum of six sessions, each of which contains seven 
steps of problem solving (see Figure 1), which are applied in a systematic 
manner towards problem resolution. The rationale is that it increases the 
patient’s understanding of the relationship between everyday problems and 
psychological symptoms. The goal of PST is to help patients to regain control 
of their lives (Figure 1).
There is evidence that PST can be an effective way of helping patients, and in 
particular patients with depression, to deal with psychological problems. One 
earlier study showed the superiority of PST over placebo but no superiority over 
amitryptiline (6). A second study showed equal results in clinical outcomes 
between patients who received PST and patients who received usual care 
from their GP (6). When community nurses provided PST the results were the 
same as for usual care from the GP, but the economic evaluation was more 
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positive for the PST group (7). Patients with minor depression who received 
PST showed the same improvement as patients who received a placebo, but 
their symptoms improved somewhat more rapidly than those of patients who 
received a placebo during the latter treatment. Patients with dysthymia who 
received PST and paroxetine showed significantly more improvement than 
patients who received a placebo (8). Compared to other GP interventions 
there is good evidence PST is effective for major depression (1).
PST provided by nurses as a potential option
Patients with psychological problems need more time than is available in 
general practice. The usual 10-minute consultation with a GP is generally too 
short to explain and explore these psychological problems. To complicate 
matters more, these problems are often interwoven with physical issues such 
as fatigue and sleeplessness. Furthermore, patients are not unambiguous in 
presenting their symptoms (9). Given this fact, in combination with the high 
prevalence of psychological problems in primary care, treating these patients 
will result in a shift of tasks to nurses. Especially nurses who are skilled in 
working with psychiatric patients, may become indispensable in primary 
care(10). Nurses can be successfully trained in the techniques of PST and can 
provide effective PST for primary care patients (11). Recent results show that 
a CBT protocol for panic disorder can adhered by a therapist with minimal 
of or no CBT experience (12).
There are several issues which stimulate further investigation. First, PST may 
be the way forward in the Netherlands, where GPs have a heavy workload 
and patients need better-tailored collaborative forms of care, focused on self-
help and education.
There are still very few nurses working in Dutch general practice and although 
preliminary experiments are taking place to enhance and define the role of 
nurses in primary care, PST could be a welcome innovation in their task profile. 
So, innovative projects in primary care in the Netherlands are needed.
Secondly, there is a lack of research outcomes on the effectiveness of talking 
treatment for anxiety symptoms in patients. In this trial, patients with 
depressive as well as anxiety symptoms will be included. Only one study 
has reported substantially better outcomes for primary care patients with 
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panic disorder, who received CBT and pharmacotherapy from a therapist 
with minimal or no CBT experience, like a nurse, than patients with usual 
care only from their GP (13).
Third, PST in primary care could prevent or stimulate a referral to secondary 
care for patients with complaints, which cannot be treated in primary care. 
This would also stimulate better-tailored collaborative forms of care and 
prevent the deterioration of complaints.
The primary aim of the present trial is therefore to investigate whether PST 
for patients with psychological problems provided by nurses in primary care, 
is effective.
Methods
Design
A randomised, controlled trial is being carried out to evaluate the effects 
of PST. At least 160 Primary care patients will be included; 80 will receive 
usual care and PST and 80 will receive usual care only. At baseline, after 
the intervention and after 3 and 9 months the patients will be asked to fill 
in a questionnaire, and at baseline and after 9 months they will be asked 
to cooperate in a (diagnostic) telephonic interview. Primary outcome is the 
reduction of symptoms, and other outcomes measured are improvement 
in problem solving skills, psychological and physical well being, daily 
functioning, social support, coping styles, problem evaluation and health 
care utilization.
The Medical Ethics Committee of the VU Medical Centre in Amsterdam 
approved the study design.
Study population
The study population will consist of Dutch-speaking adults (18+) who 
visited a participating GP more than three times in the last six months. 
To asses whether psychological problems are present, the General Health 
Questionnaire 12 item version (GHQ-12) will be used for screening (14). 
Schreuders_v5.indd   25 19-07-2007   08:30:01
Chapter 2
26
At random we visited the participating GP practices to ask patients to fill 
in our screening questionnaire while they where waiting to see their GP. If 
they had a score negative score on more then three out of twelve questions 
(indicating the presence of psychological problems) and if they were willing 
to participate, they were included. Patients were excluded from the study if 
they: received any treatment in mental health care; suffered from a severe 
(psychical) disease or personality-disorder; accepted no other explanation 
for their complaints than a somatic rationale; and patients with an non-
consistent medication for anxiety or depression. Patients with severe drug 
addictions, suicidal wishes or mental retardation were excluded.
Intervention: usual care and PST provided by nurses
Consistent with earlier research on PST training skills (11), the nurses in this RCT 
were trained for two days by experienced supervisors who were also members 
of the original Oxford research group(6). The nurses were closely supervised by 
means of video and audiotapes. A CBT supervisor will carry out supervision after 
the training, for one hour every three weeks. The nurses will deliver audiotapes 
and PST protocol forms to the supervisor. Consistent with advice in earlier 
research (11) before the nurses started treating patients in the trial, they treated 
four patients to practice their problem-solving skills after the training.
The patients are also seen by their GP for general health management if 
necessary. 
Usual care: health management provided by the GP
The consult is intended to be as natural as possible so that the GP will not 
influence the quality of the usual care provided. Many GPs use the guidelines 
issued by the Dutch College of General Practitioners (15). The guidelines 
for psychological complaints such as anxiety and depression describe 
management options as (anti-anxiety of anti-depressant) medication and/or 
‘watchful waiting’ if a referral seems unnecessary (16).
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Outcome measures
Primary outcome: reduction of symptoms measured with the HADS.
The Hospital Anxiety and Depression Scale (HADS, (17)) is used to monitor 
symptom levels of anxiety and depression in the study population. The question-
naire consists of 14 items to which answers can be given on a 4-point scale 
(0-3). The HADS is considered to be unbiased by coexisting general medical 
conditions, and changes in HADS scores can therefore be used to calculate an 
objective effect size of the treatment provided (calculations described in ‘Sample 
size’). In the Dutch validation of the HADS (17) the primary care patients have 
a mean of 6.2 (SD 3.8)for anxiety and 3.7(SD 3.4) for depression with a total 
mean of 9.9 (SD 6.1). Reliability for these patients is a Cronbach’s alpha of 
.82 for the total score. The HADS was found to perform well in assessing the 
severity of symptoms (18). 
Secondary outcomes: reduction of symptoms measured with the PHQ.
The Patient Health Questionnaire (PHQ) is designed to facilitate the diagnosis 
of common mental disorders in primary care patients (19). The PHQ is a self-
report version of the Primary Care Evaluation of Mental Disorders (PRIME-MD). 
The questions do not only focus on mood disorders but also about functional 
impairments, life stressors and specific events (such as menstruation, pregnancy 
and childbirth). Its diagnostic validity is good, and patients feel comfortable 
filling in the questionnaire (20). There is a 15-item questionnaire for men and 
a 16- item questionnaire for women, and the scoring range varies. We consider 
that a decrease in the score on this questionnaire after the intervention 
represents a reduction in mood disorders, functional impairments, life stressors 
and distress about specific events. 
Improvement in problem-solving skills
The Social Problem Solving Skills- Revised (SPSI-R, 15) is a 52-item, self-report 
inventory, which was designed by D’Zurilla to measure problem-solving 
skills (21). The SPSI-R consists of five factors: 1) positive problem orientation 
(PPO), 2) negative problem orientation (NPO), 3) rational problem solving 
(RPS), 4) impulsivity/carelessness style (ICS) and, 5) avoidance style (AS). 
Schreuders_v5.indd   27 19-07-2007   08:30:02
Chapter 2
28
Alphas for these five scales range from .76 to .92 (22) an test-retest reliability 
ranges from .72 to .88 (23).
Psychological and physical well-being
This is measured with the Short Form-36 (SF-36) which contains 36 questions and 
standardized response options and relating to eight different areas (multi-item): 
physical functioning, role limitations due to psychical health problems, bodily 
pain, general health perceptions, vitality, social functioning, role limitations due 
tot emotional problems, and general mental health (24). The mean alpha for 
reliability in the general population is good, as well as validity, which makes the 
SF-36 a practical instrument for use in the general population.
Social support
The Social Support Inventory is a questionnaire that comprises 20 descriptions 
of social support pertaining to emotional support, informative support, social 
companionship, or instrumental support. Together these items give an overall 
representation of satisfaction with social support (the perceived adequacy). 
It is a reliable and brief measurement instrument that is not influenced by 
psychological distress (25).
Coping-styles
The Ways of Coping Questionnaire (WAYS) (the Dutch adaption is called the 
VOMS: Vragenlijst over Omgaan met Situaties) is based on the Lazarus and 
Folkman transactional coping theory of (19). It measures coping processes, 
not coping dispositions or styles. The WAYS can assess and identify thoughts 
and actions that individuals use to cope with stressful encounters in everyday 
life. The WAYS measures eight coping factors: confrontive coping, distancing, 
self-controlling, seeking social support, accepting responsibility escape-
avoidance, planful problem solving, and positive reappraisal.
Rumination: Actual scientific reports suggest that rumination is a significant, 
and probably prognostic, factor for depression. The rumination scale (RRS) 
measures the extend to which people ruminate (26). Rumination is seen as a 
coping style and characterizes depressive mood. The reliability was good and 
its validity is satisfying (27;28).
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Problem evaluation
This was assessed with a brief, qualitative questionnaire about medical 
outcomes, the care, the illness and the treatment of the patients, as experienced 
by the patients, to complement all the quantitative questionnaires. We chose 
the PSYCHLOPS( also known in the literature as MYMOP(29;30)) to evaluate 
the problems patients experience and the progress they make over time.
Health care utilization
The Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness 
(Tic-P) was used to measure the amount of health care received by the patients 
and to register sickness absence from work(31). Furthermore, we chose 
the EQ-5D (or Euroqol, (32)) because this is a standardized measurement 
instrument for a wide range of health conditions which provides a simple 
descriptive profile and a single index value for health status. The EQ-5D (or 
EuroQol) was originally designed to complement other instruments such as 
the SF-36, and it is administered to assess a patient’s general health status, 
in 5 dimensions: mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression[1]. Because each of the five dimensions can be sub-divided 
into 3 levels a total of 243 health states can be assessed. Using the Dolan 
model (1997) the total score will be expressed in utilities (33).The official 
Dutch translation of the Euroqol will be administered (33;34). Incremental 
cost-effectiveness ratios will be calculated, in which the difference in costs 
between intervention subjects and control subjects will be divided by the 
difference in effects between both groups. Incremental cost-utility ratios will 
also be calculated in which the difference in costs between the two groups 
will be divided by the difference in QALYs gained between the two groups.
Power/ analysis
Randomisation takes place at patient level. To evaluate the effects of the 
randomisation, descriptive statistics will be used to compare the baseline 
measurements of the two groups. If necessary, differences between baseline 
variables on relevant characteristics (such as baseline HADS score) will be 
entered as covariates in the analysis.
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To detect a clinically relevant difference between interventions (effect size 
of 0.4) with the primary outcome measure HADS (power of .90 and an 
alpha of .05) 130 completers are needed. In both conditions there will be 
65 completers. We estimate the drop-out rate to be on 20%, so we therefore 
need 160 participants. If 20 practices cooperate, we will need to include 8 
patients in every practice. We expect a non-response of 50%, so we will need 
to screen 16 patients in every practice. In a sample of patients with mixed 
symptoms of anxiety and depression, Cropper et al. (35) observed a mean 
overall HADS score of 6.25 at baseline. In the Dutch validation (17) the 
primary care patients have a mean on anxiety of 6.2 (SD 3.8) and 3.7(SD 3.4) 
for depression with a total mean of 9.9 (SD6.1). We consider a standardized 
mean difference (SMD) of 0.4 (p=0,05) on the primary outcome (HADS) to 
represent a relevant improvement in the PST group versus the usual care 
group (36). 
Analysis
Linear regression models will be used to examine differences in investigate 
on the HADS. Scores will be entered in a repeated measure design (GLM), and 
(optional) covariates will be differences at baseline level. Repeated measures 
with several independent variables will be used to investigate differences 
in improvement in all secondary outcome measures between groups. The 
analyses will be performed on a per protocol basis (‘completers’), as well 
as according to the ‘intention-to-treat’ principle. Trend analyses will also 
allow ‘last observation carried forward’ analyses. To assess whether protocol 
deviations have caused bias, the results of the intention-to-treat analyses will 
be compared with analyses of the PST group, including the completers. 
Sample size
A GP in the Netherlands has an average of 80 consultations a week (children 
excluded). Six of the patients who consult their GP had done so more than three 
times in the previous six months and were ‘frequent attenders’. With a response 
of 50%, three patients a week per general practice will be sufficient, but: only 
one third of them will meet the inclusion criteria. This implies that 1 patient can 
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be included per practice per week. To include 160 patients with a screening in 
two practices per week, will take approximately one and a half years.
Arguments for publishing a design
The primary goal of presenting the design of this study before the results are 
available is to offer the reader the opportunity to consider the methodological 
quality of this study more critically and this is also a benefit for caregivers, 
because this extensive information provides more insight into the practical 
applications of the study intervention.
Publication also prevents publication-and-analysis bias. Trials that lead to 
adverse or negative results are less likely to be submitted for publication (37). 
This can be avoided by publishing a priori the design of a study and the plans 
for analysis. Not only will the researchers be more inclined to publish the 
results, but transparency will also be increased and, in any case, data can be 
requested from the researcher for inclusion in a systematic review.
Conclusion
The results of this study will provide statistical evidence of the effects of 
PST for patients with psychological problems who are frequent attenders in 
primary care, and indications for optimal treatment and referral. The results 
of this research can also contribute to the further development of specific 
tasks for practice nurses in primary care.
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Abstract
Background
The prevalence of patients with mental health problems in general practice is 
high, and in at least one third of these problems last for six months or longer. 
Patients with these problems take up more time during a consultation, and 
attend more frequently.
Aim
The present study investigated the effectiveness of problem solving treatment 
for primary care patients with mental health problems. Our hypothesis was 
that patients receiving problem solving treatment from a nurse would have 
less symptoms after three months, or a lower attendance rate, compared to 
patients receiving usual care from the general practitioner (GP). 
Design of the study
Randomised clinical trial.
Setting
Twelve general practices in Amsterdam and twelve nurses from a mental 
health care institution.
Method
A sample of patients (18+) were screened for mental health problems with the 
general health questionnaire (GHQ-12) in the waiting room of the general 
practices, were randomised. Patients receiving problem solving treatment 
were required to complete 4-6 treatment sessions, and patients in the control 
group were treated as usual by the GP.
Results
We found no significant difference between the groups in terms of improved 
psychopathology or a decrease in attendance rate. Post-hoc analyses showed 
a sub-group of patients with more severe pathology who may benefit from 
problem solving treatment. 
Schreuders_v5.indd   36 19-07-2007   08:30:07
37
Primary care patients with mental health problems. Outcome of a randomised clinical trial
Conclusion
Our main results show that problem solving treatment provided by a nurse 
adds little to usual care from the GP for frequent attenders with mental health 
problems; post-hoc analyses show that there may be a sub-group of more 
severely depressed patients who benefit from problem solving treatment. 
Keywords
problem solving, treatment, general practice, (public health) nurses, anxiety, 
depression
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background
The prevalence of attenders with mental health problems in general practice 
is high (1). Most of the patients with these problems suffer from anxiety and 
depression symptoms, which affect up to a third of all patients in general 
practice (2). It is also known that health problems related to anxiety and/or 
depression have a major impact on the quality of life of patients, and at least 
one third of these problems last for six months or longer (3). 
For the general practitioner (GP), consultations with patients who have health 
problems related to anxiety and depression frequently pose a challenge, for 
which there are two main reasons. Firstly, the limited time that is available: 
patients take up more time during a consultation, and attend more frequently 
than other patients, often with vague reasons for their visit (4). Secondly, the 
implementation of treatment is often difficult: the guidelines for anxiety and 
depressive disorders recommend psychotropic drugs, counselling or referral 
to specialist services for anxiety and depressive disorders (5;6). Nevertheless, 
many patients cannot be treated according to these guidelines because they 
have different preferences. Although psycho pharmacy may be effective, it does 
sometimes have unwanted side effects, there can be a risk of dependency, and 
patient adherence is often poor (7). Most patients prefer structured counselling 
(8), but they seldom receive it (9). Due to the demand-driven time-restricted 
nature of general practice they usually receive unstructured generic counselling. 
There is also evidence that in those patients who receive a more structured form 
of psychological intervention from their GP, its effectiveness is not assessed (1). 
In order to optimise the care that is provided for patients with symptoms of 
anxiety and/or depression, evidence-based treatment covering a wide range 
of mental health problems is desirable, feasible and necessary (10).
The aim of this study was to evaluate a brief psychological treatment that can be 
provided in primary care: problem solving treatment. This has been evaluated in 
earlier studies, and there is evidence that it can be provided by nurses, and that it 
can also be an effective way of helping patients with mental health problems in 
primary care by helping them to solve every day problems, in particular patients 
who suffer from major depression (11;12). 
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In this study we investigated the effect of problem solving treatment on feelings 
of depression and anxiety, and on attendance rates, when provided by mental 
health nurses for patients with mental health problems in primary care. Patients 
are defined here as patients with three or more consultations in the previous six 
months. Our hypothesis was that patients receiving problem solving treatment 
from a nurse would have less symptoms after three months or a lower attendance 
rate, compared to patients receiving usual care from the GP.
Methods
Patient recruitment and selection
Details of the design of the study have been previously published (13), but 
we will briefly summarize it again here. Between November 2003 and May 
2005 we screened consecutive patients for the presence of mental health 
problems on days our research assistant was stationed at one of our twelve 
general practices in and around Amsterdam, in the Netherlands. Patients 
who were eligible for participation were those who screened positive (i.e. a 
negative score on more then three out of twelve questions) on the General 
Health Questionnaire (GHQ-12) (14-16), had visited their GP three times 
or more in the previous six months, were over 18 years of age, were able 
to speak Dutch, and were willing to undergo brief psychological treatment. 
Psychiatric and medical co morbidities were not reasons for exclusion, 
unless they were potentially life threatening (i.e. suicidal ideation, terminal 
medical illness) or were expected to severely limit the patient’s participation 
or adherence to treatment (i.e. psychosis, dementia, severe personality 
disorders, severe somatisation, current substance abuse). Patients who had 
received treatment from a mental health professional during the previous 
year were also excluded. 
Recruitment of community nurses
Nurses from one of the mental health care organisations in Amsterdam 
were willing to co operate, and this resulted in the participation of twelve 
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enthusiastic nurses with varying nursing backgrounds, but all with working 
experience in mental health care. 
The training programme
The training programme consisted of two parts. In the first part, the nurses 
were trained by two members of the group of researchers that developed 
problem solving treatment for primary care, L. Mynors-Wallis and I. Davies (17). 
This training consisted of workshops that focused on the features of mental 
health problems in primary care, the theory and rationale of problem solving 
treatment and role-play exercises supervised by the trainers. The role-playings 
was videotaped and evaluated. In the second part, the nurses treated four pilot 
patients, closely supervised by a cognitive behavioural therapist (CBT) supervisor. 
Audio-tapes were made during treatment of the pilot patients and feedback was 
given during supervision sessions. They also filled in forms during the sessions 
according to the problem solving treatment protocols, and these were handed 
in to the researcher at the end of the treatment. After completing these two parts 
of the training the nurses could start treating patients in the trial in the same 
manner as they had treated the pilot patients.
Figure 1. Problem Solving Treatment
 
•
•
•
•
Problem Solving Treatment contains of seven stages:
1. Explanation and rationale
2. Problem definition
4. Generating solutions
3. Establishing achievable goals
5. Selecting preferred solution
6. Implementing solution
7. Evaluation of progress
Characteristics:
4-6 sessions
first session max. 60 min. next sessions max 30 min
strategy for coping with present and future problems
role of therapist decreasing patient taking over control
Figure 1. Problem Solving Treatment
Schreuders_v5.indd   40 19-07-2007   08:30:09
41
Primary care patients with mental health problems. Outcome of a randomised clinical trial
Problem solving treatment
D’Zurilla and Goldfried defined problem solving therapy for the first time in 
1971 (18). In 1995, Gath and Mynors-Wallis conducted an experiment based 
on a fundamental form of this therapy in primary care and called it (problem 
solving) treatment . The treatment is brief (less than four hours) and focuses 
on practical skill building. It consists of a maximum of six sessions, each of 
which contains seven steps of problem solving (see Figure 1) which are applied 
in a systematic manner to achieve problem resolution for everyday problems 
such as: not being able to do all the housework in one day or not being able 
to do activities they like. The rationale is that the treatment increases the 
patient’s understanding of the relationship between everyday problems and 
psychological symptoms. The goal of problem solving treatment is to stimulate 
an active attitude towards these everyday problems and by reaching goals in 
the everyday problems achieve a reduction in mental health problems.
Randomised clinical trial
After the intake assessments, the patients were randomly assigned to one 
of the two treatment conditions: 1) problem solving treatment provided by 
a mental health nurse, or 2) usual care from the GP. Randomisation was 
performed at patient level; half of the patients were randomised either to the 
problem solving treatment group or to a usual care group. Random permuted 
blocks of 4 were made to ensure the equal distribution of patients. An external 
researcher performed this concealed allocation, and independent interviewers 
evaluated the patients. All patients gave written informed consent before 
randomisation.
Assessments
The participants received (written) questionnaires at baseline, and after the 
intervention (three months later). The primary outcome was reduction of 
symptom severity measured by the Hospital Anxiety and Depression Scale 
(HADS, (19). The secondary outcome was reduction of symptoms measured 
with the Patient Health Questionnaire (PHQ) (20). This provides diagnoses 
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at a syndrome level in this research; improvement in problem solving skills 
according to the Social Problem Solving Inventory-Revised (21) ; psychological 
and physical well-being by the Short-Form 36 (22). For a detailed description 
of the assessment questionnaires we refer to a for-mentioned the article 
describing the design of the study (13). 
Power calculation
We based the calculation of the study-size on a clinically relevant difference 
between interventions with an effect-size of 0.4 on our primary outcome 
HADS measurement (23). We estimated a total score of 8 with an SD of 4 and a 
difference of 2 points in the intervention group. To detect this difference with 
a two-sided significance level (α) of 0.05 and a power (1-β) of 0.80, we needed 
a sample size of 130 patients, divided into two groups of 65 (24). Taking into 
account a dropout rate of 20%, we estimated a sample size of 160.
Statistical analysis
We first studied baseline similarity. Secondly, we compared differences within 
the groups with paired t-tests to assess changes over time. Thirdly, we used 
(univariate) general linear models and (binary) logistic regression with baseline 
measurement as a covariate to investigate the effect of the intervention (i.e., 
the difference in outcome between the problem solving treatment group and 
the usual care after three months, corrected for outcome measurements at 
baseline). The level of significance was set at p<0.05. Finally, we performed 
two post-hoc analyses. All analysis was performed in SPSS. 
Results
Pre-treatment characteristics
Between October 2003 and March 2005, 130 patients completed the assessments. 
The patients who dropped out at baseline and were lost to follow up (n=45) 
showed no differences with regard to age or gender compared to those who 
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completed the study. Dropout was 21%(18/87) in the control group and 31% 
(27/88) for problem solving treatment, with no significant difference between 
the groups (X²= 2.287, df=1, p=.166). Reasons for dropout were: unable to 
be contracted; no longer any problems; too much strain. A flowchart of the 
participants can be found in Figure 2. 
Figure 2. Flowchart of participants
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Refused to  
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Assessed for
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N=2133 
N=742
 A score  of  ≥4  on GHQ
N=622   ≥ 3 consultations GP in 
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- Post  test only N=1 
N=120  not 
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Not willing to 
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- Lost  to post test N=3
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As expected, baseline assessment was similar for both groups. The baseline 
characteristics can be found in Table 1.
Table 1. Baseline characteristics.
UC
N (%)
PST
N (%)
Total
N (%)
Age M (SD) 52.5(15.1) 53.3(14.4) 52.8(14.7)
Female sex 46(75.4) 46(66.7) 92(70.8)
Married/cohabiting 28(45.9) 33(47.8) 61(46.9)
Education level
Low 
Medium 
High
16(26.2)
18(29.5)
23(37.7)
13(18.8)
21(30.4)
29(42)
29(22.3)
39(30)
52(40)
Minimal 1 diagnoses MINI 37(60.7) 39(56.5) 76(58.5)
GHQ M(SD) 7.84(2.7) 7.36(2.4) 7.58(2.6)
Main treatment effects
Symptom severity
The HADS depression symptom level improved significantly for patients in the 
problem solving treatment group (mean difference 1.92; [95 % CI] 0.95; 2.88) but 
also for patients in the control group (mean difference 1.26; [95 % CI] 0.42; 2.10). 
The HADS anxiety symptom level also improved significantly post-treatment in 
both groups (problem solving treatment mean difference 1.45, [95% CI] .51; 2.39 
vs. UC mean difference 1.43; [95% CI .63; 2.24). After correction for baseline 
scores, post-test values did not reach statistical significance (shown in Table 2). 
Problem solving skills
The standardised total score of the SPSI-R improved significantly at post-
treatment for patients in the problem solving treatment group as well as for 
patients in the control group (problem solving treatment mean difference 
–5.46, [95% CI] –8.10; -2.81 vs. UC mean difference -2.00; [95% CI] -3.95;-
.052). Analysis of covariance with pre-treatment as covariate showed no 
significant difference at post-treatment (Table 2). 
vPsychological and physical well-being 
The SF-36 has two composite scales for mental and physical well-being. After 
treatment, patients in the problem solving treatment group experienced an 
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improvement in their mental well-being (mean difference -3.77; [95 % CI] -
6.33;-1.98.), as well as in their physical well being (mean difference -2.84; [95 % 
CI]-4.91;-.78). Patients in the control group showed no significant improvement. 
However, after correction for baseline values, this effect disappeared (Table 2).
Mental health problems 
The PHQ allows sub-threshold and full diagnoses (at syndrome level). We analysed 
the three most frequently occurring diagnosis; major depressive disorder, panic 
disorder and somatic disorder. For all three diagnoses no significant differences 
between the groups were found with X² tests on post treatment.
Frequency of attendance
The frequency of attendance in both groups declined significantly with 1,5 
visits in twelve weeks. Paired t-tests showed a significant decline in both 
groups, but after correction for baseline no differences were found (Table 2).
 
Table 2. ANCOVA’s and logistic regression for differential treatment effects with the pre-test as 
covariate.
HADS M (SD)
Anxiety pre
Anxiety post
Depression pre
Depression post
Total pre
Total post
8.97 (4.1)
7.54 (4.1)
7.67 (4.0)
6.41 (4.0)
16.54 (7.0)
13.91 (7.4)
8.17 (3.9)
6.72 (3.7)
7.12 (3.8)
5.20 (3.8)
15.25 (7.0)
11.92 (6.9)
F(1,128)=.346
F(1,128)=2.41
F(1,128)=1.37
.558
.123
.243
SPSI-R M(SD)
SPSI-R  pre
SPSI-R post
90.94 (13.1)
92.06 (12.3)
85.49 (12.4)
90.06 (10.9) F(1,122)=1.83 .179
SF-36 M (SD)
Physical Components Score pre
Physical Components Score post
Mental Components Score pre
Mental Components Score post
41.17 (11.4)
43.43 (12.0)
37.75 (11.1)
40.20 (12.4)
46.49 (1.7)
49.33 (11.3)
38.11 (10.3)
41.78 (10.9)
F(1,128)=2.25
F(1,128)=.740
.136
.391
Frequency of consulting GP M(SD)
Pre
Post
3.28 (2.7)
1.47 (2.1)
2.83 (3.0)
1.39 (1.5) F(1,117)=.007 .932
Post-hoc analyses
To evaluate the effects on the most relevant mental health problems, 
depression and anxiety, we dichotomised the HADS score (≥ 8 yes/no). This 
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is the clinically relevant HADS cut-off point for case finding in the general 
practice population (19;25;26). Taking this cut-off into account for the 
depression-subscale, we found a significant improvement in patients in the 
problem solving treatment group who were suffering from a depression (26 
on pre treatment and 15 on post treatment vs. 33 on pre treatment and 30 on 
post treatment for usual care). In the problem solving treatment group the 
symptoms of depression declined significantly, in contrast with the scores in 
the control group (OR=. 651, [95% CI].447;.948). For the HADS anxiety sub-
scale we found no significant difference between the groups.
Our second post-hoc analysis was based on the hypothesis that patients with 
one or more mental health problems would benefit (more) from problem 
solving treatment. Therefore we separated (≥1 yes/no) the diagnose measured 
with the PHQ. Every patient who scored 1 or more diagnoses was included 
in the analysis. Pre-treatment there were 35 patients in the problem solving 
treatment group with 1 or more diagnose, and post-treatment there were only 
17. We investigated the effect of the interventions with logistic regression. In 
this respect, logistic regression with the baseline number of PHQ diagnoses as 
covariate, confirmed this hypothesis because it revealed a main effect in the 
problem solving treatment group concerning the number of the diagnoses 
(OR.675, [95% CI] .448;.964). The patients in control group decreased from 
44 to 35. We found no significant decline in the number of diagnoses in the 
control group.
Discussion
Summary of main findings
In our trial we have demonstrated that problem solving treatment provided 
by a nurse adds little to usual care from the GP for patients with mental 
health problems. However, our post-hoc-analyses showed an outcome 
which suggests that there may be a sub-group of patients with more severe 
psychopathology who may benefit more from problem solving treatment. 
The results of this trial also suggest that problem solving treatment, provided 
by a trained nurse, for patients who are severely depressed (HADS ≥ 8) or for 
patients with one or more diagnoses (at syndrome level) may be an effective 
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intervention. For all other primary care patients with mental health problems 
our study provides no convincing evidence that GPs should recommend 
problem solving treatment provided by nurses.
Comparison with existing literature
Recently, another trial in primary care trial focused on problem solving 
treatment provided by community health nurses. The patients who received 
problem solving treatment were compared to patients who received usual 
care from their GP. Both groups were treated for common mental health 
problems. This trial demonstrated a lack of effect (16). Our findings point 
in the same direction .In earlier studies a clear effect of problem solving 
treatment provided by nurses was found in patients with major depression 
(12; 27; 28). The diagnostic heterogeneity of general practice may limit the 
potential effect of problem solving treatment (29). 
Strengths and limitations
Because of the sample size, this trial makes a relevant qualitative contribution 
to the existing knowledge about problem solving treatment and the 
heterogeneous population of GP. Our heterogeneous study population is 
typical for general practice, but we may not have identified a homogenous 
sample of patients, as our entry criterion of the number of consultations 
in the last six months was perhaps too low. In the Netherlands in 2005 a 
mean consult frequency of 3 visits a year was considered an average (31). But, 
taking the ages into account (no limit to age) we cannot state this is a very 
sick group. A higher threshold then, would be recommended. We chose the 
period of six months because of the high rates of spontaneous recovery in 
this period (32) and we were convinced this would also be valid for our target 
group. Now, it may have included too many patients with mild or self-limiting 
problems that could potentially be harmful. This could have influenced the 
effectiveness of the study and perhaps explains the 25% dropout rate. Half of 
the patients who were approached (N=311) did not participate in this project 
and we have no information about their motivation. More research is needed 
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to determine if these results can be replicated in a recruited sub-group with 
a higher number of patients, and also investigate how to identify this group 
in a feasible way in general practice. 
Implications for further research
To decide which general practice patients profit most from problem solving 
treatment provided by nurses, the GP should assess the patients’ ability to 
‘psychologize’ (i.e., in contrast with ‘somatize’) and the high-severity of the 
depression and/or multiple psychopathology. The substantial number of 
dropouts in our study supports the usual stepped care approach of general 
practice: many patients had ‘no longer had problems anymore’. Joining the 
conclusion of Kendrick (16); we propose to limit specialised problem solving 
treatment to patients who do not recover with usual GP care. Altogether 
we suggest more research to identify specific subgroups that benefit most 
from problem solving treatment, or to develop additional primary care 
interventions for these patients.
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Abstract
Background
Patients in primary care who experience mental health problems frequently 
visit their general practitioner (GP), while no adequate treatment is yet 
available.
Objectives
Effectiveness of problem-solving treatment given by a specialized nurse, for 
GP patients with mental health problems, nine months after the trial.
Methods
A RCT is conducted for these patients where problem solving treatment and 
usual GP care were compared.
Results
Time effects were found for the problem-solving group, especially for problem 
solving skills. No main effects were found. The suggestion of effectiveness in 
subgroups in the three-month data could not be replicated after nine months. 
Predictors of improvement were studied, and one predictor was found; being 
younger then 50 years. 
Conclusion
We suggest to restrict problem-solving treatment as performed by a specially 
trained nurse to patients with the more serious mental health conditions 
in a stepped care model. We presume that for many patients in this trial, 
problem-solving treatment may have been offered too early.
Keywords
problem-solving treatment, general practitioner, mental health problems. 
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background
In primary care the estimated prevalence of psychological problems varies, 
but we can safely state that patients with these kind of problems visit their 
general practitioner quite frequently (1).  Therefore, mental health care is a 
core activity of primary care (2). The general practitioner (GP) has become 
the gate-keeper for all medical but also for psychological care, which means a 
substantially expanded task (3;4). Patients with mental health problems have 
a considerable social impairment, especially when they suffer from affective 
disorders (5). The financial costs of these problems are large, for both society 
and the individual, especially in days lost from work (6). For GPs, to advise 
patients effectively how to deal with mental health problems better tools are 
urgently required.
For many of the psychological problems in primary care, no evidence-based 
treatment was available (7) until 1996. Then, Problem Solving Treatment 
(PST) was developed and used for the first time in a randomised clinical 
trial (RCT) (8). Since then many trials and reviews have been performed 
about the effects of PST, but few were in primary care (1;9-14) and non of 
them investigated patients with general mental health problems. To further 
develop the evidence for the effectiveness of problem-solving treatment in 
primary care, we conducted a RCT where the effects of PST were compared 
to the usual care of the general practitioner for patients with mental health 
problems. We conducted three measurements, at baseline, after three 
months and after nine months. Primary outcome was the Hospital Anxiety 
and Depression Scale (HADS, (15)). The data after three months showed 
no clinical or statistical significant main differences between the usual 
care group and the problem-solving group. We did find time-effects for 
both groups; they both improved. Further research lead to the suggestion 
of improvement for specific subgroups, namely, patients with a severe 
depression or (multiple) psychopathology (a score on the HADS greater 
or equal to eight, or having one or more diagnoses as measured by the 
Patient Health Questionnaire (PHQ, (16)). The results after three months 
are also extensively reported elsewhere (17). Consequently, one hypothesis 
we derive of the post-hoc analysis from our three months data is that PST 
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seemed to be more effective for patients with more severe symptoms (17). 
Therefore, the aim of this study is to investigate if more improvement 
can be found for patients who received problem-solving treatment. We 
also expect some (socio demographic an personality) factors to predict 
improvement of mental health problems, like gender, SES, social support, 
rumination, taking responsibility and avoidance. In this paper, not only 
the nine-month results are presented, but also our results about predictors 
of improvement.
Methods
Design 
Data of the trial were collected in the Problem Solving Treatment (PST) 
project Amsterdam, the Netherlands, between November 2003 and May 
2005. We set up a randomised controlled trial (RCT) with two arms: usual 
care from the GP and PST from a nurse. An independent researcher did 
random allocation in the two arms. The design and the outcomes after three 
months are published elsewhere (18;19). This report is about the follow-up 
data, which are collected nine months after baseline. 
Subjects
We recruited 127 representative patients with mental health problems. 
Patients were pre-screened by use of the General Health Questionnaire (GHQ-
12, (20)) and when patients scored 4 or more, and were eligible, we assessed 
their mental and physical health by written questionnaires at pre-treatment, 
post-treatment (three-months) and follow-up (nine-months). A flow chart of 
patients can be found in Figure 1.
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Figure 1. Flowchart of participants
N=1
Patiens received
N=2486GHQ
Refused to
participate
N=353
Assessed for
eligibility
N=2133
N=622 3 consultations GP in past six
months + score of 4 on GHQ
Not willing to
participate N=311
Not meeting inclusion
criteriaN=136
Eligible and
randomised
N=175
Allocated to CAU only
Outcome Completers N=69
Lost to follow-up
Follow-up N=68
N=2
Outcome Completers N=61
Lost to follow-up
Follow-up N=59
N=87
N=14
N=3
N=1
- Non-responders pre-test
- Lost to post test
- Post test only
Allocated to CAU + PST N=88
N=24
N=2
N=1
- Non-responders pre-test
- Lost to post test
- Post test only
Intervention
PST is a brief (less than four hours) treatment that focuses on practical skill 
building. The goal of PST is to stimulate an active attitude towards everyday 
problems and, hereby, to achieve a reduction in mental health problems. 
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Patients were offered a four to six PST sessions. An overview of the steps 
taken in this treatment can be found in figure 2.
Figure 2. Problem Solving Treatment
 
•
•
•
•
Problem Solving Treatment contains of seven stages:
1. Explanation and rationale
2. Problem definition
4. Generating solutions
3. Establishing achievable goals
5. Selecting preferred solution
6. Implementing solution
7. Evaluation of progress
Characteristics:
4-6 sessions
first session max. 60 min. next sessions max 30 min
strategy for coping with present and future problems
role of therapist decreasing patient taking over control
Figure 1. Problem Solving Treatment
Outcomes
Primary outcome measure was the well-validated self-report Hospital 
Anxiety and Depression Scale (HADS). Higher scores indicate higher levels 
of depression and anxiety. Other outcome measures were the Patient Health 
Questionnaire (PHQ, (21)), Social Problem Solving Inventory (SPSI-R, (22)) 
and the Social Functioning-36 (SF-36(23)).t The results were analysed by 
using paired t-tests between pre-treatment and follow-up for completers 
analysis. The next step was analysing by covariance (ANCOVA) or binary 
logistic regression for non-parametric data. 
Predictors of improvement 
An improvement of 4 points or more on the primary outcome HADS between 
the baseline and follow-up was considered a relevant criterion for clinically 
relevant improvement (15; 24-26). Firstly, we examined associations by using 
Pearson’s correlations. We used (univariate) general linear models to investigate 
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the effect on the outcome, an finally the predictors were used in a (linear and 
logistic) multivariate regression, forward stepwise. Potential predictors were 
socio-demographic variables (education, income and age); mental health 
problems (PHQ); personal characteristics such as the level of problem-solving 
skills (SPSI-R), or other relevant psychological characteristics like the Ways of 
Coping Questionnaire (WCQ) and the Rumination Response Scale (RRS). 
Results intervention
There were 127 patients who completed the follow-up when the HADS was 
used as a criterion. Patients with follow-up had a lower mean age (52.57; SD 
14.7), and were more likely to be female (N=89, 70,1 %), compared to those 
with no follow-up (N=3) who had a mean age of (66, SD 9.2) and who were 
all female.
Outcome
Main effects
No statistical significant differences were found between the problem solving 
treatment group and usual care group after nine months, when corrected 
for baseline measurements.  There were no interactions found between 
the measurements and the groups. There was no effect modification found 
between outcome and groups. Results can be found in Table 1.
Table 1. Follow-up data (nine months) of main effects.
UC
M(SD)
PST
M(SD)
F p
Total score HADS pre 
Total score HADS follow-up
16.43(7.0)
13.07(7.1)
15.03(7.0)
12.05(8.3) F(1,125)= 0.00 .93
Total score SPSI pre
Total score SPSI follow-up
90.37(13.9)
91.37(12.4)
85.68(12.8)
91.19(14.4) F(1,108)= 2.19 .14
SF-36 mental pre
SF-36 mental follow-up
37.91(11.1)
43.29(10.5)
38.26(10.4)
44.2(11.1) F(1.125)= 0.19 .66
SF-36 psychical pre
SF-36 psychical follow-up
41.18(11.5)
44.71(12.0)
46.32(10.7)
47.43(10.6) F(1.125)= 0.40 .52
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Time-effects
Although the results did not reach statistical significance, we did observe 
time effects for the HADS, which means both groups, improved for anxiety 
and depression. The SF-36 mental component showed both groups improved 
on this component during the nine months of the trial, again there were no 
significant differences between the groups. But, there were some differences 
in outcome measurement between the groups; the usual care group showed 
a time effect for the psychical component of the SF-36 were the PST group 
didn’t. The group with patients who received PST scored a significantly 
different improvement in problem solving skills compared to usual care; 
problem solving treatment upgrades the patients’ problem solving skills. 
Usual care helps to improve physical health.
Table 2. Follow-up data (nine months) of time-effects.
Pre treatment
M(SD)
Follow-up
M(SD)
T p
Total score HADS PST
Total score HADS UC
15.03(7.0)
16.43(7.0)
12.05(8.3)
13.07(7.1)
-3.33
-4.44
.00
.00
Total score SPSI PST
Total score SPSI UC
85.68(12.8)
90.37(13.9)
91.19(14.4)
91.37(12.4)
 3.23
.769
.00
.44
SF-36 mental PST
SF-36 mental UC
38.26(10.4)
37.91(11.1)
44.2(11.1)
43.29(10.5)
-4.49
-3.51
.00
.00
SF-36 psychical PST
SF-36 psychical UC
46.32(10.7)
41.18(11.5)
47.43(10.6)
44.71(12.0)
-1.04
-2.70
.30
.00
Post-hoc analysis
The three-month results suggested that PST might be more effective for 
those with more symptoms. After nine months we did not resemble this (OR 
0.68, CI 95% 0.32-1.47, p= 0.32). Moreover, when depressed patients scored 
eight or more after filling in the HADS, de data after three months showed 
a potential improvement for the patients who received problem solving 
treatment. Again, we could not resemble this after nine months (OR 1.09, CI 
95% 0.48-2.45, p= 0.84). 
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Results predictors of improvement
We found one statistical significant correlation between the predictor age 
and improvement on the primary outcome, the HADS (r= -0.21, p=0.02). The 
(univariate) general linear model showed (OR= 0.57, CI 95% 0.35–0.92, p=0.02). 
All predictors were used in a multiple logistic regression model (forward stepwise), 
and we found the same statistically significant predictor; being younger then 50 
(OR 0.97, CI 95% 0.94-0.99, p=0.04).  Because of the low correlation coefficients 
it is obviously there are no significant outcomes of the analysis, therefore we 
show the variables included with their correlations in Table 3.
Table 3. Results predictors of improvement.
Pearson’s 
correlation
p
Age -0.21 0.02
Sex  0.05 0.54
Marital status -0.01 0.98
Ethnicity -.056 0.53
Income -0.05 0.64
Somatic disorder  0.12 0.19
Major depression -0.06 0.53
Panic disorder -0.02 0.85
Problem solving skills -0.06 0.55
Rumination  0.02 0.86
Coping – planfull problem solving  0.18 0.07
Coping- seeking social support -0.08 0.44
Coping- wishful thinking  0.04 0.07
Coping- accepting responsibility  0.07 0.43
Coping- escape-avoidance  0.16 0.08
Coping- positive reappraisal  0.07 0.05
Discussion
Although PST by nurses has proven itself in several primary care trials (8; 14; 
27-30), we could not replicate this effect. We could also not find predictors 
for response. There are some possible explanations for this phenomenon. 
First: as we intentionally included this relativity healthy group, improvement 
because of a benign natural course could not be excluded. Second: perhaps 
the intervention was not strong enough for patients who could benefit? 
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Third: more trials in primary care give these kinds of results, maybe we 
should conclude that an expectant policy by the GP frequently is sufficient 
as there was little difference between a specialized intervention effect and 
the usual care. 
In a recent Cochrane review about counselling in primary care, significantly 
lower psychological symptoms were scored after counselling when compared 
to usual care from the GP (31). This leaves us wondering if the lack of 
effectiveness is due to the quality of care in several countries? 
Fourth: we could be too early with this specialised intervention. A recent 
study of Kendrick (10) where trained nurses also carried out PST, showed the 
same effects. They suggest using PST only in a stepped care model, and taken 
the natural course of psychological problems into account, we agree with 
this concept. 
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Abstract
Background
Patient-generated outcome measurements about psychological problems 
stay close to how patients perceive their own problems, and focus less on 
disorder concepts, such as depression and anxiety. Although psychological 
problems are pervasive in primary care, we know little of how patients with 
psychological symptoms perceive their problems. As patient-generated 
instruments best describe the problems from the perspective of the patient, 
they may therefore also show higher sensitivity to change when used to 
evaluate treatment for mental health problems in primary care. 
Methods
In a RCT with 100 participating patients, we evaluated a psychological 
intervention in primary care. Patients also filled in the Hospital Anxiety 
and Depression Scale (HADS) and also the ‘Psychological Outcome Profiles’ 
(PSYCHLOPS).  To describe how patients report psychological problems and 
to explore whether these resemble depression and anxiety symptoms, answers 
to the ‘open’ questions of the PSYCHLOPS were categorized according to the 
International Classification of Primary Care (ICPC). To evaluate sensitivity to 
change, effect-sizes of PSYCHLOPS and the HADS were compared.
Results
Social problems were mentioned most frequently about relationships in 
the first place and about work in the second place. Depressive or anxious 
symptoms were seldom mentioned. The PSYCHLOPS showed a higher effect-
size than the HADS (1.26 vs. 0.54). 
Conclusions
Psychological problems were mostly perceived to be social issues. The 
PSYCHLOPS proved to be feasible, and more sensitive to change than the 
HADS. Therefore, this study supports further use of the PSYCHLOPS as a 
promising outcome instrument for both practical and research purposes. 
Conventional outcomes like the HADS give lower effect-sizes and may 
underestimate the effects of interventions. 
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Introduction
The literature on effects of interventions in primary care shows use of mostly 
expert derived, symptom checklists, for example the Hospital Anxiety and 
Depression Scale, (HADS (1)). The HADS is a patient-centered questionnaire 
because it measures subjective well being, but it consist of questions 
determined by the expert and mostly rates symptoms. The answers are ratings 
on a scale from 0-3 to acknowledge the subjective well being. Other examples 
of patient centered questionnaires are the Social Functioning-36 (SF-36, (2)) 
or the General Health Questionnaire (GHQ, (3)). All questionnaires are often 
used in daily practice, but also in scientific research. 
We plead for a patient generated measurement, this is a measurement, 
which is not only patient-centered, but the items measured are also defined 
by the patient. Instead of suggesting symptoms, the patients can list the 
problems, symptoms or complaints they experience. Therefore, the patient 
is the expert who decides what might be important aspects of their lives. 
These kind of questionnaires have several advantages for use in primary 
care: it offers a detailed description of problems which can be used for daily 
practice as well as research, but also gives a priority in problems without the 
need to transform them into a diagnosis. Recently, such an instrument was 
developed: the Psychological Outcomes Profiles (PSYCHLOPS (4-6)). The 
PSYCHLOPS is a simple practical tool that focuses on problems patients’ 
experience, and also indicates levels of functional impairment and well 
being. It allows researchers to conduct an evidence-based evaluation of 
(psychological) treatment effects. The PSYCHLOPS has been validated in 
2005, and it reports good reliability and may also be sensitive to change 
(7). The PSYCHLOPS is used for evaluation of psychological treatments, 
put into practice for patients suffering of mental health problems. Mental 
health care is a core activity in primary care (8). Most if this morbidity 
consists of anxiety and depression (9). The reasons for encounter of patients 
with mental health problems are mostly not presented as a part of the 
clinical concepts of depression and anxiety. Recognition of the symptoms 
representing anxiety and depression is difficult (10). 
The first aim of this study is to describe reasons for the encounter for patients 
with mental problems (as reported in the PSYCHLOPS) and to compare 
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outcomes of PSYCHLOPS and HADS on sensitivity to change for patients in 
a RCT. We calculated effect-sizes of PSYCHLOPS and HADS for the patients 
who received the intervention.  
The general practitioner uses a classification system for causes, diagnoses and 
consequences; the International Classification of Primary Care (ICPC, (11)). 
This classification system is the main ordering principle of patient data in 
primary care and because it is available in 19 languages it is used in several 
countries, including The Netherlands. Its conversion structure with the 
International Classification of Diseases (ICD-10) allows the highest possible 
level of specificity in a patient’s problem list necessary in patient care, while 
the compatibility of the ICPC drug codes with the Anatomic Therapeutic 
Chemical Classification Index allows the systematic inclusion of data on 
prescription (12). 
The second aim of this study is to explore to what extent presented problems 
and ICPC classifications overlap. We will discuss the ‘problem evaluation’ 
measured by the PSYCHLOPS by categorising them in ICPC classifications. 
We are interested what patients report as a problem and if we could divide 
these problems in ICPC classifications. 
Methods
Study design
We conducted a randomized clinical trial to investigate whether Problem 
Solving Treatment (PST) for patients with psychological problems is 
effective compared to usual care from the general practitioner (GP). We 
described the details of the protocol in an earlier published article (7). PST 
is a brief treatment and focuses on practical skill building. It consists of a 
maximum of six sessions, each of which contains seven steps of problem 
solving, which are applied in a systematic manner towards problem 
resolution (13). Before and after the treatment we asked patients to fill 
in a self-administered questionnaire. This questionnaire included the 
PSYCHLOPS and the HADS. The HADS was used to investigate effectiveness 
on a symptom level of depression and anxiety and for comparison with 
the PYCHLOPS.  Of all patients 100 both completed the PSYCHLOPS and 
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the HADS. Of them, 57 received usual care (UC) from their GP and 43 UC 
and PST. Outcomes were the reduction of symptoms (HADS) and problem 
evaluation (PSYCHLOPS). 
Study population
The study population consisted of Dutch-speaking adults (18+) who 
visited a participating GP more than three times in the last six months. To 
assess whether psychological problems were present, the General Health 
Questionnaire 12 item version (GHQ-12) was used (3). Patients were included 
in this study when they filled in a negative score on more than three out 
of twelve questions (indicating the presence of psychological problems (3)), 
and when they were willing to participate. In the total group of completers 
(N=100) the mean age of the completers was 53 years (range 20 - 86) and 
86% were female. In the PST group (N=43) the mean age of the completers 
was 52.53 years (13.56)(range 25 - 85), 74.4% were female. In the UC group 
(N=57) the mean age of the completers was 52.79 (15.28)(range 20-86) and 
63.2% were female.
PSYCHLOPS
The PSYCHLOPS is a short, self-report, idiosyncratic questionnaire, and 
consists of four questions (Figure 1). This instrument was a continuation 
of the MYMOP (Measure Yourself Medical Outcome Profile (14)), which 
was used to assess physical illness. The PSYCHLOPS has recently been 
validated and reports a Cronbach’s alpha of 0.79 pre-treatment and 0.87 
post-treatment (4). 
The first question of the PYCHLOPS asks: ‘choose the problem that troubles 
you the most. Please write it in the box below’. After description, the patients 
is asked to score the problem on a six-point scale, ranging from ‘not at all 
affected’ to ‘severely affected’.  The duration of the problem is also elicited. 
The second question asks for any other problems in the same manner of 
description and scoring. The third question is about describing and scoring 
of functional impairment and finally, the fourth question is about scoring 
(not describing) well being (Figure 1). The second measurement holds the 
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original responses of the free text questions of the start of the treatment, in 
identical boxes and the patient is asked to score the same items again, using 
identical scales. The well being question is repeated and a fifth question 
is added, asking how the patient ‘feels in themselves’ now that therapy 
is finished (Figure 2). The answer can be reported on a six-point scale 
(range 0-5), ranging from ‘much worse’ to ‘much better’. The total score 
is derived by the mean of all scales (range 0-20 pre-treatment, range 0-25 
post-treatment). 
Statistical methods
Based on the problems patients were bothered with at the moment they 
entered the study, we coded the problems according to the ICPC (Table 1).
Two authors (BS, HvM) assigned the problems to classified relevant ICPC 
chapters. The effect-size (ES) was obtained for the PSYCHLOPS total score 
and the HADS total score by using Cohen’s ‘d’ definition (15): Mpre-Mpost/
Sdbaseline as in (4). The calculations of the HADS were carried out in the 
same manner. 
Results
Psychological problems in primary care
Most problems were social (42), but also psychological (34), musculoskeletal 
(8) or general (16). The most distinct problems were about relationships (20). 
The problems patients report in this category were for example: my mother 
must attend a nursing home, my son is addicted to hard drugs or not seeing my 
grandchildren. In ICPC, this is coded as the category of social problems (Table 
1). The most distinct problems besides relationships were problems with 
work or money (N=22). The problems patients report in this category are 
for example: not able to find a job; worrying about money or changes at work. 
In the ICPC we coded this also as social problems. Besides these two striking 
categories we found other categories, which we extensively described in 
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Table 1. Problems were seldom described as depression or anxiety symptoms 
(N=16).
Table 1. Categories of answers to PSYCHLOPS pre treatment as defined by ICPC.
ICPC code Problems
Social problems (N=42)
Relationships (20)
My mother must attend a nursing home after she fell
Illness of children (N=2)
Divorce problems
Relationship problems with partner 
My son is addicted to hard drugs
I am having an argument with my brother and sister in law
Sickness of partner (N=3)
Not seeing my grandchildren (N=3)
My wife has dementia
Genetic illness in the family (N2)
Illness parents
Conflict with my brother and sister
My husband (N=2)
Work problems (22)
Not able to find a job (N=8)
Changes at work
Will I be able to keep working in the future?
Worrying about money (N=6)
Financial consequences of not being able to work
Having debts (N=4)
Moving
Psychological problems (N=34)
Other mental health problems (18)
Not living the life I want
Worrying about health (N=4)
Lack of concentration
Lack of emotional balance
  Being in a hurry and being late
Feeling insecure
Should I continue like this or make different choices?
To fall short
Not being able to live like normal people
Loosing elasticity
Being able to keep doing all my activities
Sexual problem (N=3)
War/trauma
Depression (10)
Depressive feelings
Suffering from a depression
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Loneliness (N=2)
Feeling sad
Waiting to get a depression again
Having no energy (N=4)
Anxiety (6)
Stress (N=4)
Anxiety
Bothered by nervous feelings
Musculoskeletal (N=8)
Back pain (N=2)
Pain in joint/shoulder/leg/knee (N=5)
Not being able to walk
General (N=16) 
Health (N=3)
Pain
Heart rhythm disturbance
Pain in left breast
Fluid in my legs
The same thing happens to me as to my friend
Skin disease
Bellyache
Dizziness (N=2)
Diabetes check up
Problems with my voice
Moving my arms
Arthritis
Comparing PSYCHLOPS and HADS
The total scores of the difference between the pre-treatment and post 
treatment for the PST group gave an effect-size of 1.26 for the PYCHLOPS 
and 0.54 for the HADS for outcome after three months (Table 2a and 2b). ES 
for the control groups were 0.91 vs. 0.33 (Table 2a and 2b).
Table 2a. PSYCHLOPS outcome and change after three months.
N=100 Pre-therapy
M(SD)
Post-therapy
M(SD)
Change 
M(SD)
SD
baseline
Effect 
size
Total PST(N=57)
Total UC(N=43)
3.54(0.72)
3.79(0.67)
2.63(1.18)
3.17(1.11)
0.91(1.26)
0.61(1.05)
0.72
0.67
1.26
0.91
Table 2b. HADS outcome and change after three months.
N=100 Pre-therapy
M(SD)
Post-therapy
M(SD)
Change
M(SD)
 SD 
baseline
Effect 
size
Total PST(N=57)
Total UC(N=43)
15.95(6.73)
16.89(7.19)
12.28(7.30)  
14.49(7.40)
3.67(5.74)
2.40(5.77)
6.73
7.19
0.54
0.33
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Discussion
The categories of problems patients reported in the PSYCHLOPS gave us 
insight in the denomination of problems reported by the population in 
primary care. The categories we found showed that symptoms of depression 
and anxiety are seldom presented (or interpreted) as such in primary care. 
The PSYCHLOPS was more sensitive to change than the HADS according to 
the effect-sizes. Conventional outcomes may underestimate the effects of 
psychological treatments up till now. The PSYCHLOPS has been measured 
in one non-randomised trial and shows a high sensitivity to change when 
Cohen’s d is calculated by use of baseline SD. To make comparison possible, 
we used the same formula. One could question if the high ES would be 
equal when a pooled pre-post SD was used. Although these were somewhat 
lower (0.94 PSYCHLOPS vs. 0.52 HADS) the difference is still remarkable. 
In the psychometric study a pooled SD lowered the ES from 1.53 to 1.37. 
Therefore, effect sizes calculated by PSYCHLOPS stay high and are stable 
in measuring outcome for treatment of psychological problems in primary 
care. Interestingly, this finding also indicates that the effect of the PST 
intervention was larger than with the HADS as the primary outcome. In a 
recent meta-analysis about the effect of PST, measured on a symptom level, 
mean standardized ES are found of 0.34 to 0.83, depending on the model (16). 
Our study shows that the ES calculated with a patient generated outcome is 
remarkably higher, for PST as well as the control group. 
This high ES could be caused by the possibility of identification of factors of 
importance using the PYCHLOPS that may be obscured by the HADS because 
of the responses, which are not allocated to pre-determined categories. 
We wondered if subdivisions in causes, consequences and diagnoses could be 
found in ICPC codes, and we were surprised at the categories we found. The 
most used category is the one about social problems, consisting of relationship 
and working problems. Diagnostic categories are rare; sixteen patients 
reported clear problems of depression and the same for anxiety. Therefore, 
the PSYCHLOPS can be a tool to create better mutual understanding by using 
the patients’ own words to articulate the perception of their problems.
More research is needed in combination with PST and patient generated 
measurements to identify the conditions in which the best effects are 
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accomplished. By matching the problems with the ICPC codes we have a tool 
to find subgroups in the heterogeneous population of (frequently) visiting 
patients. These subgroups can be used to optimise future health care research 
and therefore damming heterogeneity that is a possible cause for the low effect-
sizes in primary care trials. It can also be used as an instrument for stepped care 
(17). In conclusion we could say the PSYCHLOPS is a very useful and sensitive 
instrument to evaluate psychological treatment in primary care.
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A questionnaire about you and how you are feeling 
We hope that this questionnaire will help us to have a better understanding of your feelings.  You don’t have to fill in this form, but if you do, 
all your answers will be confidential.  Please answer the four questions on this page and then return this form to your therapist or counsellor. 
We will ask you to fill in just one more form like this near the end of your course of therapy or counselling.
This questionnaire is called the Psychological Outcome Profiles questionnaire (PSYCHLOPS). It has been written 
by STaRNet, a primary care research network funded by the NHS Executive, London Region. This version was 
written in April 2002 and was based on a questionnaire devised by Charlotte Paterson which was first published in 
the British Medical Journal in 1996.
©   Copyright:  STaRNet London 
Figure 1
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A follow-up questionnaire about you and how you are feeling 
You kindly helped us by filling in one of these questionnaires before your therapy or counselling started.  This is the follow-up questionnaire.  
We would be grateful if you would fill this in so we can see what effect therapy or counselling has had for you.  You don’t have to fill in this 
form, but if you do, all your answers will be confidential.  Please answer the five questions on this page and then return this form to your 
therapist or counsellor.  
This questionnaire is called the Psychological Outcome Profiles questionnaire (PSYCHLOPS). It has been written 
by STaRNet, a primary care research network funded by the NHS Executive, London Region. This version was 
written in April 2002 and was based on a questionnaire devised by Charlotte Paterson which was first published in 
the British Medical Journal in 1996.
©   Copyright:  STaRNet London 
Figure 2
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Abstract
Background
Mental health problems are common in primary care and are associated with 
increased disability and health care costs. Problem Solving Treatment (PST) 
might be effectively delivered to these patients by nurses in primary care.
Aim
To evaluate the cost-effectiveness of PST by mental health nurses compared 
with usual care (UC) by the general practitioner for patients with mental 
health problems.
Design of study
Economic evaluation alongside a randomised clinical trial.
Setting
Primary care.
Methods
Patients with a positive General Health Questionnaire score (score ≥ 4) and 
who visited their general practitioner at least three times during the past 6 
months were eligible. Resource use was measured from a societal perspective 
using a validated questionnaire. Bootstrapping was used to analyse costs and 
cost-effectiveness of PST compared with UC.
Results
There were no statistically significant differences in clinical outcomes 
at 9 months. Mean total costs were €4200 in the PST group and €7105 
in the UC group. Despite this large difference (€2906), costs were not 
statistically significantly different between the two groups (95% CI 
-5652;35). The cost-effectiveness analyses confirmed the findings of no 
difference in clinical effects and a tendency towards lower costs in the PST 
group. After multiple imputation this difference disappeared and PST was 
not cost-effective in comparison with UC.
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Conclusion
Based on this study PST is not cost-effective in comparison with UC. Future 
research should focus on specific patient groups, for example depressed 
patients or patients who do not recover or deteriorate after a period of 
watchful waiting.
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Introduction
Mental health problems are common both in the community and in primary 
care, with affective disorders being the most commonly occurring problems 
(1-3). The disability burden of these mental health problems is enormous (4). 
Moreover, mental health problems are associated with increased health care 
costs, thus causing an economic burden as well (5-7).
Most patients with mental health problems are treated in primary care (8). 
The perceived burden on general practitioners (GPs) when treating patients 
with mental health problems is higher than when treating other patients 
(9). Treatment mainly consists of treatment with psychotropic drugs 
(10;11). However, these drugs have disadvantages such as side effects, a risk 
of dependency and poor compliance. Many patients prefer psychological 
treatments over psychotropic drugs (12;13). There is little evidence on the 
effectiveness of psychological treatments delivered by GPs (14). Also, it is 
questionable whether GPs have time to provide psychological treatment for 
all patients with mental health problems. Psychological treatments could 
be made more widely available, if other health care providers (for example 
nurses) could provide these treatments.
Problem Solving Treatment (PST) is a form of psychological treatment that 
has been shown to be effective for depression in primary care and can be 
effectively delivered by nurses or GPs (15;16). However, for unselected 
patients with mental health problems evidence of the effectiveness of PST 
was less clear and PST was associated with significantly higher health care 
costs than usual GP care (17;18). The aim of this study was to assess the cost-
effectiveness of PST by mental health nurses compared with usual GP care for 
primary care patients with mental health problems.
Methods
This economic evaluation was conducted alongside a randomised controlled 
trial assessing the effectiveness of PST compared with usual GP care for 
primary care patients with mental health problems. The trial was performed 
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in 12 general practices in and around Amsterdam, The Netherlands, between 
November 2003 and May 2005. Block randomisation was used to allocate 
patients to either PST provided by a mental health care nurse or usual 
care from the GP. Randomisation was performed by an external researcher 
and independent researchers evaluated the patients. The Medical Ethical 
Committee of the University Medical Center in Amsterdam approved the study 
protocol. All patients gave written informed consent before randomisation. 
The methodological details of the trial are reported in full elsewhere (19).
Patient selection
Consecutive patients who visited their GP were invited by a research assistant 
to complete the General Health Questionnaire (GHQ-12) (20). Patients were 
eligible to participate in the trial if they had a score of 4 points or more on the 
GHQ-12 and visited their GP three times or more in the previous six months. 
Patients had to be 18 years or older, to be able to speak Dutch, and to be 
willing to undergo brief psychological treatment. Exclusion criteria were the 
existence of potentially life-threatening somatic and mental disorders, the 
existence of somatic and mental disorders limiting the patient’s ability to 
participate or adhere to treatment, and mental health treatment during the 
previous year.
Usual care
Treatment of mental health problems in the usual care (UC) group was 
not restricted in any way. Dutch GPs are encouraged to work according to 
guidelines issued by the Dutch College of GPs (21;22). However, they are free 
to deviate from these guidelines and organise care according to their own 
views. 
PST
PST is a brief (less than four hours) treatment that focuses on practical skill 
building. The goal of PST is to stimulate an active attitude towards everyday 
problems and, hereby, to achieve a reduction in mental health problems. 
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Twelve nurses from a mental health care organisation in Amsterdam 
participated in the trial. They were trained during two days by two researchers 
who developed PST for primary care, L. Mynors-Wallis and I. Davies. The 
training was followed by three-weekly supervision sessions with a CBT 
supervisor.
Patients were offered four to six PST sessions. The first session lasted a 
maximum of 60 minutes and following sessions a maximum of 30 minutes. 
Patients could visit their GP for UC if necessary.
Clinical outcome measures
The participants received written questionnaires at baseline, at the end of 
the intervention (three months after baseline) and at the end of follow-up 
(nine months after baseline). The primary clinical outcome was reduction 
in the severity of symptoms of anxiety and depression as measured by the 
Hospital Anxiety and Depression Scale (HADS) (23). A patient-generated 
outcome measure of change after psychological therapy named PSYCHLOPS 
(Psychological Outcome Profiles) was also used (24). Quality of life was 
measured using the EuroQol (EQ-5D) (25). The EuroQol scores were used 
to calculate utilities using both the British and the Dutch tariff (26;27). 
QALYs were calculated by multiplying the utilities with the amount of time 
a patient spent in a particular health state. Transitions between health states 
were linearly interpolated.
Cost measures
Cost data were collected from a societal perspective during 9 months. 
A specifically designed questionnaire, the TicP, with a recall period of 3 
months was used to measure resource use, absenteeism from paid work, 
and presenteeism (working less productively while still being present at 
work) (28). All direct and indirect costs were considered, because it is hard 
to discern which costs are related to mental health problems and which 
are not. If available, Dutch guideline prices were used to value resource 
use (29;30). Medication costs were valued using prices of the Royal Dutch 
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Society for Pharmacy (31). Costs of visits to complementary therapists 
were based on prices from the therapists themselves. Costs of absenteeism 
and presenteeism were calculated according to the friction cost approach 
(friction period 154 days) using the mean age- and sex-specific income of 
the Dutch population (30). According to the friction cost approach a sick 
employee is replaced after a certain amount of time (the friction period). 
After the friction period no lost productivity costs are generated. Table 1 
lists the cost categories included in the economic evaluation and the prices 
used. All costs were adjusted to the year 2004 using consumer price indices 
(32). Discounting was unnecessary, because neither costs nor benefits were 
recorded beyond 9 months.
Table 1. Prices in euros for the year 2004 used in the economic evaluation.
Category Price
General practitioner (per contact) 20.44
Physical therapist (per visit) 23.02
Social worker (per visit) 48.43
Psychologist (per visit) 76.90
Company doctor (per visit) 21.50
Regional institute for mental welfare (per visit) 125.47
In-hospital psychiatrist (per visit) 64.18 - 114.61*
Day treatment (per visit) 90.58 - 161.75*
Hospital admission (per day) 252.96 - 481.63†
Outpatient clinic (per visit) 56.66
Complementary therapist (per visit) 23.27 - 124.46‡
PST (per session)§ 49.40
Help from family/friends or paid help (per hour) 9.00
Medication depending on type and dose
Absenteeism and presenteeism depending on age and sexe
* depending on type of hospital: academic, general or psychiatric hospital
† depending on type of hospital: academic, general, rehabilitation or psychiatric hospital
‡ depending on type of therapist
§  Total PST costs based on 6 sessions: €296.42 (training €39.16, treatment €212.16, housing 
€45.10)
A cost price for PST was calculated using a bottom-up approach (Table 1). 
This costs price contains costs of time spent by PST therapists (training, 
supervision, treatment and administrative activities), costs of the training, 
housing costs and overhead costs (e.g. telephone and cleaning costs). 
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Analysis
We estimated that 65 patients in each group would be needed to detect an 
effect size of 0.4 (2-sided α=0.05, β=0.20). Taking into account a drop-out rate 
of 20%, we aimed to include 160 patients into the trial.
All analyses were intention-to-treat and limited to patients completing all 
follow-up assessments. Occasional random missing values were imputed 
with the mean value for that variable. Differences between the groups in 
improvement in HADS score, PSYCHLOPS score and QALYs gained at 9 
months were tested using t-tests.
Costs generally have a highly skewed distribution caused by many patients 
with low costs and few patients with high costs. Therefore, bias-corrected 
and accelerated bootstrapping with 2000 replications was used to compare 
costs between the two groups (33). For the cost-effectiveness analyses the 
difference in total costs between the treatment groups was compared with 
the differences in improvement in HADS and PSYCHLOPS scores, and for 
the cost-utility analysis with the difference in QALYs. Uncertainty around 
the cost-effectiveness and cost-utility ratios was calculated using the bias-
corrected percentile bootstrapping method (5000 replications) (34). The 
bootstrapped cost-effect pairs were plotted on a cost-effectiveness (CE) plane 
(35) and were used to calculate cost-effectiveness acceptability (CEA) curves 
(36).
Sensitivity analyses
A number of sensitivity analyses were performed to assess the robustness 
of the results. In the first sensitivity analysis lost productivity costs were 
calculated according to the human capital approach. This approach assumes 
that lost productivity costs are generated until an employee recovers and 
returns to work, or until the moment of death or retirement.  In the second 
sensitivity analysis the impact of the costs of PST was investigated. In one 
analysis, training costs were excluded from the PST costs and in another 
analysis it was assumed that all patients received 6 PST sessions. In the third 
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sensitivity analysis patients with indirect costs higher than €30,000 were 
excluded. In a last sensitivity analysis, multiple imputation (MI) based on 
the Multivariate Imputation by Chained Equations (MICE) procedure(37) 
was used to impute missing cost and effect data.
Results
During the inclusion period, 2486 patients were invited to complete the GHQ-
12 of whom 353 refused to participate. Of the 2133 patients who completed 
the GHQ-12, 622 patients had a score of 4 or more on the GHQ-12 and visited 
their GP three times or more in the past 6 months. Three hundred and eleven 
patients were unwilling to participate in the trial and 136 did not meet the 
inclusion criteria leaving 175 patients to be included in the trial of whom 88 were 
randomised to the PST group and 87 to the UC group. Complete cost data were 
available for 56 (64%) of the PST patients and 65 (75%) of the UC patients. There 
were no significant differences in baseline characteristics between patients with 
and without complete cost data. At baseline the utility based on the EuroQol 
(both tariffs) was significantly lower in UC patients than in PST patients. There 
were no other significant differences in clinical and demographic characteristics 
between the treatment groups at baseline (Table 2). 
Table 2. Baseline characteristics of participants with complete cost data. Presented are numbers 
(%) unless stated otherwise.
PST
(n=56)
Usual care
(n=65)
Mean (SD) age (years) 53 (14) 52 (15)
Female 43 (77%) 42 (65%)
Married/cohabiting 25 (45%) 30 (46%)
Eduction level
Low 13 (23%) 12 (19%)
Medium 16 (29%) 22 (34%)
High 25 (45%) 26(40%)
Unknown 2 (4%) 5 (8%)
Born in The Netherlands 49 (88%) 53 (82%)
Mean EuroQol utility UK (SD) 0.69 (0.18) 0.58 (0.32)
Mean EuroQol utility NL (SD) 0.72 (0.17) 0.63 (0.28)
Mean HADS score (SD) 15.1 (7.2) 16.6 (7.0)
Mean Psychlops score (SD) 3.6 (0.7) 3.8 (0.7)
UK = United Kingdom; NL = The Netherlands; HADS = Hospital Anxiety Depression Scale; 
PSYCHLOPS = Psychological Outcome Profiles
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Clinical effects
After 9 months the mean improvement in HADS score was -3.4 (SD 6.7) 
in PST patients and -3.4 (SD 6.1) in UC patients. This difference was not 
statistically significant (mean difference 0.02, 95% CI -2.3;2.4). The mean 
improvement in PSYCHLOPS score after 9 months was -1.1 (SD 1.1) in the 
PST group and -1.4 (SD 1.4) in the UC group, resulting in a mean difference 
of 0.2 (95% CI -0.3;0.7), which was not statistically significant. 
Figure 1 shows the course of the utilities according to the EuroQol based on 
the Dutch tariff. The differences in utility between the PST and UC group 
were significant on baseline and after 3 months, but not after 9 months. The 
improvement in utility after 9 months in the PST group (0.04, SD 0.21) was 
smaller than in the UC group (0.08, SD 0.34), but this difference was not 
statistically significant (mean difference -0.04, 95% CI -0.14;0.07). The number 
of QALYs gained after 9 months in the PST group was significantly larger than 
in the UC group (mean difference 0.1, 95% CI 0.02;0.1). However, regression 
analysis showed that the difference in QALYs gained was caused by the 
difference in utility at baseline (β=0.416, p=0.000) and not by the intervention 
(β=-0.037, p= 0.090). The results for the British tariff were similar.
Figure 1. Course of utilities according to the EuroQol over 9 months
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Health care utilization
Table 3 presents the health care utilization in the PST and the UC group and 
the differences between the two treatment groups at 9 months. During the 
study period, 51 (91%) PST patients and 57 (88%) UC patients visited the 
general practitioner at least once. Thirty-two (36%) PST patients received 
some form of mental health care (referral to a mental health care provider or 
prescription of either an antidepressant or benzodiazepine) in comparison 
with 33 (38%) UC patients during follow-up. In the PST group 24 (44%) 
patients and in the UC group 31 (51%) patients had a paid job at baseline. 
Of patients with a paid job at baseline 15 (63%) PST patients and 22 (71%) 
UC patients were absent from paid work for at least one day and 7 (29%) PST 
patients and 13 (42%) UC patients were absent for more than one month.
Table 3. Health care utilization over 9 months of patients with complete cost data. Presented 
are means (SD) and mean differences (95% CI).
Category PST
(n=56)
Usual care
(n=65)
Difference
Primary care
General practitioner [no contacts] 4.1 (3.3) 4.8 (4.5) -0.7 (-2.1 ; 0.8)
Physiotherapist [no contacts] 5.5 (10.3) 6.0 (11.0) -0.5 (-4.4 ; 3.4)
Social worker [no contacts] 0.3 (1.9) 0.2 (0.8)  0.1 (-0.5 ; 0.5)
Psychologist [no contacts] 1.1 (5.0) 1.0 (2.7)  0.1 (-1.3 ; 1.6)
Secondary care
Outpatient clinic [no contacts] 2.3 (3.4) 4.2 (10.2) -1.9 (-4.6 ; 0.8)
Regional institute for mental welfare [no contacts] 0.3 (0.9) 0.5 (1.9) -0.2 (-0.8 ; 0.3)
In-hospital psychiatrist [no contacts] 0.1 (0.7) 0.2 (0.9) -0.1 (-0.4 ; 0.2)
Day treatment [no half days] 0 (0) 0 (0) --
Admission [no days] 0.3 (1.1) 1.3 (5.8) -1.0 (-2.4 ; 0.5)
Home care [no hours] 4.2 (16.0) 7.9 (29.4) -3.7 (-12.4 ; 5.0)
Complementary therapists [no contacts] 1.4 (3.8) 1.8 (4.8) -0.4 (-1.9 ; 1.2)
Company docter [no contacts] 0.4 (1.4) 0.8 (1.6) -0.4 (-0.9 ; 0.2)
Medication [no deliveries] 7.0 (6.8) 7.4 (6.5) -0.4 (-2.8 ; 2.0)
PST [no contacts] 4.1 (2.1) --
Help from family/friends or paid help [no hours] 14.9 (32.8) 12.5 (34.2)  2.4 (-9.8 ; 14.5)
Absenteeism [no days] 19.5 (54.8) 29.0 (62.4) -9.5 (-30.8 ; 11.8)
Presenteeism [no days] 3.8 (12.9) 7.2 (19.9) -3.4 (-10.0 ; 2.7)
PST = Problem Solving Treatment
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Costs
Table 4 presents the mean total costs in the PST and UC group and the 
differences between the two groups for different cost categories after 9 
months. Both direct and indirect costs in the PST group were lower than in 
the UC group. Indirect costs were the greatest contributor to mean total costs 
in both treatment groups and to the difference in mean total costs between 
the treatment groups. Presenteeism had a large share in total indirect costs 
in both treatment groups (PST group 18% and UC group 24%). PST patients 
received on average four PST sessions amounting to a mean cost of €200 (SD 
104). In spite of this, mean total costs in the PST group were €2906 lower 
than in the UC group, but this difference was not statistically significant 
(95% CI -5652;35). The difference in total indirect costs was statistically 
significant. 
Table 4. Costs over 9 months of patients with complete cost data. Presented are means (SD) 
and mean differences (95% CI).
Cost category PST
(n=56)
Usual care
(n=65)
Difference
Direct costs 1449 (1560) 1913 (3615) -464 (-1297 ; 463)
Direct medical costs 1315 (1405) 1800 (3584) -485 (-1215 ; 447)
Primary care 311 (557) 323 (422) -12 (-216 ; 176)
General practitioner 84 (68) 98 (91) -14 (-41 ; 15)
Physiotherapist 127 (238) 138 (254) -11 (-99 ; 78)
Other care 99 (396) 87 (215)  13 (-121 ; 127)
Secondary care 292 (489) 884 (3295) -592 (-935 ; 295)
Outpatient clinic 128 (192) 237 (579) -109 (-195 ; 41)
Admissions 115 (386) 565 (2768) -450 (-743 ; 268)
Other care 48 (148) 82 (275) -33 (-97 ; 47)
Home care 130 (496) 245 (913) -115 (-311 ; 177)
Complementary medicine 61 (173) 68 (172) -7 (-67 ; 58)
Company doctor 10 (31) 17 (35) -7 (-19 ; 5)
Medication 312 (917) 263 (633)  48 (-224 ; 317)
PST costs 200 (104) 0 (0)  200 (152 ; 256)
Direct non-medical costs 134 (295) 113 (308)  21 (-92 ; 119)
Indirect costs 2751 (5619) 5192 (9212) -2442 (-5142 ; -3)
Absenteeism 2263 (5314) 3946 (7728) -1683 (-3826 ; 922)
Presenteeism 488 (1537) 1247 (3667) -759 (-1503 ; 125)
Total costs 4200 (6233) 7105 (10528) -2906 (-5652 ; 35)
PST = Problem-Solving Treatment
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Total costs of contacts with mental health care providers, PST treatment and 
psychotropic medication (antidepressants and sedatives) were €372 in the 
PST group and €186 in the UC group. This difference was not statistically 
significant (mean difference €186, 95% CI -28;339).
Cost-effectiveness
For improvement in total HADS score at 9 months the incremental cost-
effectiveness ratio (ICER) was 120,727, meaning that one point improvement 
in the UC group costs €120,727. Figure 2a presents the CE plane for 
improvement in total HADS score. Only 3% of the cost-effect pairs was 
located in the upper left and right quadrants, while 47% and 50% of the cost-
effect pairs was located in the lower left and right quadrants. This confirms 
the results of the clinical and cost analyses that costs were lower in the PST 
group while there was no difference in clinical effects between both groups. 
Figure 2b shows the CEA curve calculated from the CE plane in Figure 2a. 
The curve shows that if policy makers are willing to spend up to €660 per 
point improvement on the HADS, the probability that PST is cost-effective 
in comparison with UC is larger than 95%. The results for improvement 
in PSYCHLOPS score and utility based on the EuroQol were similar to the 
results for improvement in HADS score. The cost-utility analyses for QALYs 
gained based on the EuroQol indicated that PST was more effective and less 
expensive than UC. However, these results should be cautiously interpreted 
because of the significant difference in utility at baseline.
Sensitivity analyses
Use of the human capital approach led to higher estimates of indirect and total 
costs in both treatment groups. The differences in indirect (mean difference 
-€2638, 95% CI -5864;1104) and total costs (mean difference -€3103, 95%CI -
6595;1308) were not statistically significant. Excluding training costs from the 
PST costs led to significantly lower total direct costs in the PST group than in 
the UC group (mean difference -€2932, 95% CI -5770;-14). Assuming that all 
PST patients received 6 PST sessions did not influence the results. 
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Figure 2a. Cost-effectiveness plane for improvement total HADS score after 9 months
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Figure 2a. Cost-effectiveness plane for improvement total HADS score after 9 months
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Figure 2b. Cost-effectiveness acceptability curve for improvement total HADS score after 
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Figure 2b. Cost-effectiveness acceptability curve for improvement total HADS score after 9 months
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Exclusion of patients with indirect costs higher than €30,000 resulted in 
mean total costs of €4200 (SD 6233) in the PST group and €5799 (SD 8867) in 
the UC group. The difference in total costs became smaller than in the main 
analysis (-€1600) and was not statistically significant (95% CI -4352;1144). 
After MI the pooled mean costs were €5871 in the PST group and €4790 in the 
UC group. Thus, costs in the PST group were higher than in the UC group, but 
this difference was not statistically significant (mean difference €1081, 95% 
CI -1621;3726). The cost-effectiveness analyses in the pooled data sets showed 
that PST was not cost-effective in comparison with UC.
Discussion
Summary of main findings
Our results show that there are no significant differences in costs and effects 
between PST and UC patients and that PST is not cost-effective in comparison 
with UC. However, indirect costs in the PST group were significantly lower 
than in the UC group and were the greatest contributor to the difference in 
total costs of €2906. Exclusion of 3 outliers with extremely high indirect 
costs resulted in a much smaller and statistically insignificant difference in 
total costs. Since UC patients had significantly lower utility scores at baseline 
than PST patients, we suspect that morbidity rates in the UC group were 
higher than in the PST group and that this also explains the higher costs in 
the UC group. Thus, our findings of lower costs in the PST group should be 
interpreted with care. An imputed analysis confirmed that PST was not cost-
effective in comparison with UC in this study.
Strengths and limitations of the study
This was a pragmatic trial, meaning that we tried to resemble daily clinical 
practice as much as possible. By applying as few restrictions as possible on 
patient selection and the GP’s normal care process the results of this study are 
likely to be generalisable to the rest of The Netherlands and other countries 
with similar health care systems.
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Research suggests that a considerable part of lost productivity costs in mental 
disorders is caused by reduced performance while at work (presenteeism) 
(38;39). Therefore, an important strength of this study is that both costs 
of absenteeism and presenteeism were included, whereas earlier studies 
included only costs of absenteeism (40;41).
Our study also has some limitations. First, our study was underpowered to 
detect relevant cost differences which is reflected in the wide confidence 
intervals around the cost differences. This is a common problem in 
economic evaluations alongside clinical trials. Because of the heavily skewed 
distribution of cost data, very large numbers of patients are needed to detect 
relevant cost differences (42). However, it is generally considered unethical to 
increase study sizes beyond the level needed to prove clinical effectiveness. 
Second, the number of patients that did not return all cost questionnaires 
was considerable (PST group 36%, UC group 25%). However, there were no 
significant differences between patients with and without complete cost 
data, reducing the chance of bias caused by selective drop-out. Moreover, 
the results of the imputed analysis confirmed that PST is not cost-effective in 
comparison with UC.
Comparison with existing literature
Our results can be compared with two other studies that included an economic 
evaluation of PST for primary care patients with mental health problems 
(43;44). Our results are consistent with their findings that PST is not effective 
in comparison with usual GP care. However, these studies showed that PST 
was associated with higher costs than usual GP care, while in our study lower 
costs were found in the PST group.
Implications for future research
This study shows that PST for unselected primary care patients with mental 
health problems is not cost-effective in comparison with usual GP care. Earlier 
research showed that PST is effective for treating depression in primary care 
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(45-47). In this study, PST was associated with positive effects at 3 months in 
depressed patients, but after 9 months these effects had disappeared. Research 
is needed to determine whether PST may be cost-effective in comparison 
with usual GP care for treating depression in a selected group of primary 
care patients. The cost-effectiveness of PST in comparison with usual GP care 
may also be improved by adopting a stepped care approach in which PST 
is offered to patients who do not recover or deteriorate during a period of 
‘watchful waiting’.
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The central aim of this thesis was to determine the effectiveness and cost-
effectiveness of nurse-led problem solving treatment (PST) in primary care for 
patients with mental health problems who visit the general practitioner (GP).
This final chapter discusses the issues that have been raised in previous 
chapters, beginning with an overview of the main findings concerning the 
intervention, followed by the general discussion, and results of the trial in 
light of earlier research. Recommendations for future research and general 
practice are then outlined, followed by a main conclusion.  
Main findings
Concerning the central aim, we concluded nurse-led PST for primary care for 
patients who suffer from common mental disorders was not more effective 
than usual care (UC) provided by the general practitioner (Chapter 3).
Concerning the post-hoc-analyses, there may be a sub-group of patients with 
more severe psychopathology who may benefit more from PST than other 
groups of patients. This finding is applicable to patients who are severely 
depressed, or having one or more diagnosed disorders (Chapter 3).  Regrettably, 
this effect disappeared in the long term (Chapter 4). As intended, predictors 
of recovery of common mental disorders were analysed. These analyses 
led to one predictor of recovery – an age of less than 50-years-old (Chapter 
4). In chapter 5 we compared two outcome measures; an expert-derived 
measurement and a patient-generated measurement. The patient-generated 
measurement showed a higher sensitivity of change for the patient-generated 
outcome compared to expert-derived outcome. Finally, the cost-effectiveness 
of this trial showed no significant difference in costs between both study 
groups (Chapter 6) but exploration of the cost-effectiveness data showed a 
tendency for higher costs for the patients in the UC group (Chapter 6). 
Adherence to the intervention
PST is protocolized during every session, and it was important to maintain 
this structure in order to teach the steps of problem solving to the patients. 
We took several precautionary measures to make sure the intervention is 
carried out as per protocol. Firstly, L. Mynors-Wallis and I. Davies, who helped 
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to develop Problem Solving Therapy into PST for primary care, trained the 
nurses in the trial. They were trained by making use of a treatment manual, 
a precursor from the later ‘practical guide’ (1). Following training, the nurses 
treated a number of four  ‘pilot’ patients each, while they received supervision 
from a cognitive-behavioural therapist (CBT) and supervisor. Secondly, these 
sessions (and all subsequent sessions) were audio taped and the supervisor 
and the researcher checked completed PST forms.  When the nurses were 
deemed to have treated these ‘pilot’ patients satisfactorily, they began treating 
patients who participated in the trial. During the trial, the nurses continued 
to audiotape the sessions, and provide completed PST forms. Every three 
weeks they participated in a supervision session until the end of the trial. 
Nurses could always ask for advice in between these sessions, by telephone, e-
mail or in person. When the supervisor or researcher concluded that PST was 
not carried out correctly, additional (individual) supervision sessions were 
initiated. Therefore, it can be safely stated that PST was carried satisfactorily. 
However, in every treatment there are so called ‘non-specific variables’, 
consisting of therapeutic alliance, therapist competence and adherence to 
specific treatment modality (2). The researches eliminated as much logistical 
problems as possible to stimulate therapist adherence to the treatment 
protocol (3;4). Therapeutic alliance can particularly be a contributing factor 
for effectiveness and seems predictive of treatment outcomes when based on 
patient perceptions (5-7). Besides our effort, non-specific variables could not 
be controlled, and could have had either a negative or a positive influence 
on the results of this trial. In a negative way one could say a lack of alliance 
could reduce a potential effect or cause dropout, even though intervention 
was carried out perfectly. In a positive manner these variables could help 
to not only maximize the potential effect of PST, but also, for example, to 
improve the affect of the patient. 
Intensity and duration of intervention
Intensity, frequency and duration of the intervention contribute to a change 
in outcome. A classic meta-analysis of the relationship between the duration 
of the intervention and the effect (dose-effect relations) in psychotherapy 
has been performed by Howard, Kopte, Krause and Orlinsky in 1985 (8). They 
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characterized this relationship as a negative function of treatment duration, in 
which 30% of client made measurable improvement after 2 sessions, 41% after 
4 sessions, 53% after 8 sessions, and 62% after 13 sessions (9).  By reviewing 
the literature about dose-effects relationships, two reviews showed the sufficient 
duration of PST for psychological problems in primary care (10) and for low back 
pain (11). In earlier studies the optimal amount of PST sessions was approximately 
six, the median in earlier studies was four (1). This is also in accordance with the 
results of Howard ea. Therefore, we carried out between four and six sessions. 
Patients with mental health problems possibly need more PST sessions to fully 
optimise the effect. Further research is required to determine the ideal amount 
of sessions of PST for patients with mental health problems. 
Perception of intervention by GPs
 A recent qualitative study provides an insight into how GPs perceive PST 
(12). This study showed PST was ‘perceived as being close to current practice 
approaches and potentially beneficial to both doctor and patient’. One GP 
verbalized it like:
‘PST is a re-working of an old theme of a common-sense sort of step, I suppose 
that GPs have been using it all the time, but it is less authoritarian, and it is less 
authoritative and it gives the patient a sort of a feeling that they are in control of 
their own treatment’.  It was seen not as a complex psychological approach, 
but as relatively simple, consistent with the pragmatic nature of many GPs. 
Perceived as under their control, one may ask: could it be harmful? Here are 
the answers from three different GPs:
‘I can’t see that actual problem solving itself would do harm’
‘You could argue that trying to solve their problems for them could do more harm 
then actual structured problem solving’
‘I think that on the surface problem solving is really simple but it is very easy to do 
it not properly I guess whether a GP does it of a psychiatrist or a psychologist I think 
it is a very effective intervention’. 
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When attention is paid to the origination of PST and it’s effectiveness for 
mentally retarded patients (13) and palliative care (14), in particular, there is 
no real reason to consider PST is potentially harmful. However, PST is time-
consuming for a GP, taking up 3,5 hours per patient. One GP also points out 
in this article that: ’I think that it is a major barrier perception, a lot of GPs say 
to themselves, ‘I can’t afford to spend that much time with a patient’.  Assistance 
by Mental Health workers in general practice therefore is still a necessity. 
Concluding of our trial and former trials (15-17) nurses may be useful to 
strengthen the primary care and have proven to be perfectly capable to 
provide PST.
Contrast between interventions
The content of the usual care (UC) was not standardized and we do not have 
information about the extent to which GPs paid attention to mental health 
problems or in what way they advised patients (no form of treatment was 
suggested to GPs so as not to reduce the contrast). We assumed that GPs 
would generally follow the guidelines for anxiety and depression. Although 
UC in The Netherlands is preferably based on these guidelines, it is not 
known to exactly what extent GPs follow these guidelines. An observational 
study, performed by Grol et al. (18) showed that guideline recommendations 
were followed in an average of 67% of the treatment decisions. This provides 
little insight into interventions GPs carry out when mental health is an issue. 
The trial resembled daily clinical practice as closely as possible by applying 
minimal restrictions on patient selection and GP’s normal care, and so the 
results are a good general representation of this situation in The Netherlands 
and other countries with similar health care systems. 
Screening and selection procedure
Failure to recruit sufficient GPs and patients frequently threatens the progress 
of research projects in general practice. Often, randomised clinical trials 
(RCT) have an optimistic calculation of the number of recruited patients and 
GPs. This over-optimism is called Lasagna’s law (19). The number needed to 
screen for psychological problems differs in literature. The number needed 
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to screen is defined as the number of people that need to be screened for a 
given duration to prevent one adverse event. For example, Rembol (1998) 
compared directly calculated values with estimated numbers and found that 
estimated numbers were a fourfold lower (20). Cuijpers ea. (2006) conducted 
a meta-analysis and found disappointing results for screening for depression 
in schoolchildren: 1000 to 32, which can be considered quite low (21). 
By using the screening procedure (described in Chapter 2) in the waiting 
room, it was possible to include the planned number of patients within the 
reasonable time period of 18 months, which we estimated. This screening 
procedure (which took place in the waiting room) is not conventional, and 
one disadvantage of it could be that patients can feel compelled to participate 
in the study, with potentially dropout as a consequence. We estimated a drop 
out at 20% and we calculated a drop out rate of 22% directly after including 
patients in the trial. This concerns patients who refused to complete the pre 
test. When patients participated in the trial and completed the pre test, the 
drop out rate became 6%. Drop out because of social desirability (feeling 
compelled to participate) could not be rejected. However, an advantage of this 
procedure is that the GP is relatively unburdened by recruiting patients in the 
waiting room (the GP would just check the patient’s names in the end of day 
on exclusion criteria).Also, no additional investment was necessary besides 
the usual care and the potential biased selection of patients was avoided, 
by not asking GPs to recruit patients for the study. The selection criteria 
were not necessarily psychological problems. Therefore, patients with self-
limiting problems may have been included. This may have consequences for 
the external validity of the research, as the group of patients that conclusions 
may be generalised to, is diffuse. There are two possible solutions for this 
problem. The first would be to adjust a question about the time frame in 
the screening. The second would be to invite patients for the first session 
and only discuss the contract of their treatment. This could possibly make 
the patient more responsible for his/ her treatment and recovery. If patients 
suffered from mental health problems in the month before entering the trial, 
spontaneous recovery is usually high within the first 3-6 months (22;23). 
This could have been avoided by including an explicit question about the 
duration of the mental disorders. However, this would have the disadvantage 
of not accurately resembling the patients of clinical practice. Up to this point, 
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there is no reason to doubt the randomisation of selection criteria. However, 
when studying cost-effectiveness, higher costs were found for patients in the 
UC group on baseline, suggesting a randomisation bias (randomisation was 
carried out by an external researcher). This could be explained by the fact that 
patients in the UC group suffered from higher morbidity rates than patients 
in the PST group. Patients in the UC group predominantly reported mostly 
indirect costs during the trial. According to the results of cost-effectiveness 
in this study, both absenteeism and presenteeism were included; the latter 
seemed to form a considerable part of the costs and was not often studied 
yet. This could explain the difference in results compared to earlier research 
of cost-effectiveness.
Results of the trial in the light of earlier research
There is evidence that PST can be effective in helping patients to deal with 
mental health problems (in particular those with depression). In 1995 and 
2000 trials on patients suffering from major depression showed PST is as 
effective as medication (24;25). Earlier trials on patients suffering from 
mental health problems show the same results in effectiveness (26;27), 
except one study, were long term outcome for patients who received PST was 
significantly better(28). Therefore, it can safely be stated that PST is just as 
good as antidepressants.
Until this trial, the effectiveness of PST has been investigated in two systematic 
reviews (10;11) with overall positive conclusions on its effectiveness. Since 
then, and besides the trial described in this thesis, three other important 
studies have taken place. 
Firstly, Kendrick et al, 2006 (29), published the results of a trial where nurses 
conducted PST for patients with mental health problems. The results of this 
trial resembled those presented in this thesis, with the exception of cost-
effectiveness; in the former trial PST was more expensive, but presenteeism 
was not calculated with indirect costs. Secondly, Cuijpers ea. (2007) performed 
a meta-analysis on the effectiveness of PST for depression (30). The results of 
this analysis showed an effectiveness of mean standardized effect- sizes (ES) 
of 0.34 to 0.83 depending on the model, between PST and control group. 
The ES calculated for PST only showed the smallest and non-significant ES 
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compared to other forms of problem-solving (like social problem solving or 
self-help problem solving). High ES was found for group interventions and 
with patients who met the criteria for major depression. In a recent review 
about counselling in primary care for patients with mental health problems, 
a significantly greater ES (0.28) was found for counselling in the short term 
compared with usual care. In the long term this effect disappeared (31). This 
thesis shows that the ES is medium high (not significantly) when calculated 
separately for PST (0.54)  and usual care (0.33) when calculated separately. 
According to the results of the review, both ES are calculated for short term 
(three months) and this effect reduces in the long term (nine-months). 
Thirdly, a qualitative study about GPs use of PST was undertaken (12). A 
result of all this new research provides two main insights. Firstly, although 
PST is an attractive and fairly well researched intervention, it alone is not an 
effective treatment for all primary care patients with mental health problems 
other than depression. Secondly, PST is not as effective as was thought at 
the beginning of this trial, and the results of this study help to delineate the 
indications for psychological interventions in primary care. The results of 
this study confirmed short psychological treatment such as PST can serve as 
a counterpart for care as usual, with modest effects in short term outcome, 
but provides no additional advantages in the long term.  Concerning the 
patients preference, such an intervention should be available, preferably 
given by nurses of other general practice assistance. 
Nurses can provide these interventions very well. We also think a diagnostic 
questionnaire should always precede referral for these kind of psychological 
interventions to guarantee selection of patients who suffers from problems and 
symptoms that can be effectively treated by these kind of interventions.
However, this trial was undertaken due to a lack of evidence-based 
interventions for patients with mental health problems in primary care 
(besides the guidelines for depression and anxiety). We expected and 
confirmed, PST fits in all kinds of primary care. The use of PST could be a 
clinically relevant tool for GPs as it helps advise patients on how to deal 
with mental health problems effectively. It can also be used to help patients 
explain their problems more easily and in more detail, and could also be 
integrated further in routine care or stepped care. 
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Recommendations for future research
Firstly, to strengthen the body of evidence for the effectiveness of short, 
psychological help for patients with common mental health problems in 
primary care, further research is required. This research should study the 
definition of sub-groups of patients for whom PST could be effective, or 
patients who favour PST instead of medication. 
Secondly, it could be helpful if patients were more aware of their motivation 
for treatment, and a care approach (in steps) would be recommended to 
achieve this, like the IMPACT trial, where a depression care manager escorts 
patients through all the steps undertaken in the weeks that the patient suffers 
from depression (32). PST is a module in this program, and the effectiveness 
of this trial is promising. 
Finally, it is recommended that future research uses primary outcome 
measurements which not only consist of expert-derived questionnaires, but 
patient-generated outcomes like the PSYCHLOPS – which was found to be a 
very useful and sensitive instrument in evaluating psychological treatment 
in primary care, and as an instrument for stepped care (33).
Recommendations for general practice
Mental health problems are common and are often presented as worries 
about family, work and income by patients. The GP should be aware of this, 
and could use PSYCHLOPS as an instrument to promote further studies. 
Also, patients suffering from major depression could benefit from PST (as 
indicated in earlier research, although a meta-analysis resulted in low effect-
sizes). Patients who prefer counselling instead of drug treatment could be 
adequately treated using PST, as in this trial PST proved as effective as UC. 
Finally, this study found nurses to fit in very well in daily practice, and to be 
enthusiastic about intervention. In future practice nurses should not only 
be considered as suitable providers of PST, but probably perfectly capable of 
providing other psychological treatment also.
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Main conclusion
This study provides evidence that nurse-led PST is just as effective for all 
patients with mental health problems as usual care provided by the GP. PST 
is therefore a good alternative for patients with mental health problems who 
prefer counselling instead of usual care provided by the GP. Results of this 
trial suggest, in accordance with earlier research, there could be subgroups of 
patients in general practice that could benefit more from PST (provided by 
nurses). More research is needed to identify these subgroups.
Case vignette 
In the first PST session Adrian made a list of all his problems and symptoms. 
Because of his tiredness was decided Adrian would do ‘activity scheduling’ first, 
to regain some energy and pleasure in life. He walked in the park twice a week en 
read his favourite book. In the second session Adrian felt better and was aware of 
the energy he got from doing pleasurable activities. His goal for the second session 
became : doing pleasurable activities with his wife and his sons. He made a plan to 
go to the cinema with the whole family. In the third session he worked out a plan 
to explore the city they moved into, with the whole family. The fourth session he 
chose the goal to express his feeling about work during an meeting at work. The 
fifth and last session Adrian decided to look up some of his old friends and make 
appointments with them.
In the end Adrian’s mood severely improved, as well as his relationship with his 
wife and children.  He was thinking about finding another job in the future.
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Chapter 1. Introduction
The general introduction briefly defines and describes problems in mental 
health care for GPs, and the history of intervention (including previous 
research). The aims and structure of this thesis are also discussed, and 
objectives stated. A case vignette is used to clarify the situation of patients 
with mental health problems and the difficulties GPs face in dealing with 
them.
Chapter 2. Study design
In this chapter, the study protocol is described. The protocol consists of 
a randomised controlled trial (RCT) to investigate the effectiveness and 
cost-effectiveness of Problem Solving Treatment (PST) and usual care (UC) 
compared to just usual care only. The patients in the trial, who are at least 
18-years-old and present psychological problems, receive questionnaires at 
baseline, after intervention (three months) and nine months subsequently. 
The primary outcome that is measured is a reduction in symptoms of 
depression and anxiety. Secondary outcomes measured include: improvement 
in problem solving skills; psychological and physical well-being; daily 
functioning; social support; coping styles; problem evaluation and health 
care utilization. Care, as usual, consists mostly of psycho - pharmaceuticals 
and/ or counselling. Several studies about Problem Solving Therapy (PST) 
in primary care are presented and it seems an effective way of dealing with 
emotional disorders and a promising addition to the primary care in the 
UK and USA. At that time, none of these studies was performed in the 
Netherlands.
Chapter 3. Outcome after three months
This chapter presents primary and secondary outcomes after three months, 
and provides an insight into baseline measurements. Differences between 
patient groups are compared using paired t-tests to assess changes over time, 
and (univariate) general linear models and (binary) logistic regression with 
baseline measurement were used as a covariate to investigate the effect of 
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intervention (i.e. the difference in outcome between the PST and UC groups 
after three months, corrected for outcome measurements at baseline). The 
depression symptom level improved significantly for patients in the PST 
group (mean difference 1.92; [95 % CI] 0.95;2.88), and also for patients in 
the control group (mean difference 1.26; [95 % CI] 0.42;2.10). The anxiety 
symptom level also improved significantly post-treatment in both groups 
(problem solving treatment mean difference 1.45, [95% CI] .51;2.39 vs. UC 
mean difference 1.43; [95% CI .63;2.24). After correction for baseline scores, 
post-test values did not show a statistical significance. 
Finally, two post-hoc analyses were carried out. The depression symptom 
level improved significantly for patients in the PST group (mean difference 
1.92; [95 % CI] 0.95;2.88), and also for patients in the control group (mean 
difference 1.26; [95 % CI] 0.42;2.10). The anxiety symptom level also improved 
significantly post-treatment in both groups (PST mean difference 1.45, [95% 
CI] .51;2.39 vs. UC mean difference 1.43; [95% CI .63;2.24). After correction 
for baseline scores, post-test values did not reach statistical significance. We 
therefore concluded that PST provided by a nurse adds little to usual care 
from the GP for patients with mental health problems; post-hoc analyses 
show that there may be a sub-group of more severely depressed patients who 
benefit from problem solving treatment. 
Chapter 4. Outcome after nine months and predictors of 
 improvement
The results after nine months were analysed using paired t-tests between 
pre-treatment and follow-ups for complete analysis. No statistical differences 
were found between the PST group and the UC group after nine months, 
when corrected for baseline measurements. 
Covariance (ANCOVA) analysis or binary logistic regression for non-
parametric data was then studied. There was no effect modification found in 
outcomes between the groups. Although the results did not show statistical 
significance, HADS showed improvement in anxiety and depression for 
both groups over time. The SF-36 mental component showed both groups 
improved on this component over nine months, and again, there were 
no significant differences between the groups. However, there were some 
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differences in outcome measurement between the groups; the UC group 
showed a time effect for the psychical component of the SF-36, while the PST 
group did not. The group that received PST scored a significant improvement 
in problem solving skills compared to UC. Usual care was found to help 
improve physical health. 
However, the three-month results suggested that PST may be more effective 
for those patients showing more symptoms, but not after nine months (OR 
0.68, CI 95% 0.32-1.47, p= 0.32). Only one statistical significant correlation 
was found between the predictor age and improvement on the primary 
outcome, the HADS (r= -0.21, p=0.02). The (univariate) general linear model 
showed a significant difference for the same predictor (OR= 0.57, CI 95% 
0.35–0.92, p=0.02). All predictors were used in a multiple logistic regression 
model, and the same statistically significant predictor was found; being 
younger than 50-years-old (OR 0.97, CI 95% 0.94-0.99, p=0.04).
As this study did not provide convincing evidence for long-term effectiveness, 
we concluded that (Dutch) general practitioners, as yet, should not replace 
their usual care by PST.
Chapter 5. Comparison of instruments to evaluate psychological 
treatment in primary care
In Chapter 5 a psychological intervention in primary care using different 
instruments is evaluated. Patients filled in HADS and ‘Psychological Outcome 
Profiles’ (PSYCHLOPS). To evaluate sensitivity to change, effect-sizes of 
PSYCHLOPS and HADS were compared. Answers to ‘open’ questions in 
PSYCHLOPS were categorised according to the International Classification of 
Primary Care (ICPC), to further describe how patients report problems, and 
to explore whether they were similar to depression and anxiety symptoms. 
PSYCHLOPS showed a higher effect-size than HADS (1.26 vs. 0.54). Patient 
worries were mainly concerned with social problems, firstly relationships and 
work secondly. Depressive or anxious symptoms were seldom mentioned. 
Therefore, it was concluded that PSYCHLOPS was a more feasible instrument 
than HADS, and more sensitive to change. Conventional outcomes like HADS 
give lower effect-sizes and may underestimate the effects of interventions. 
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Chapter 6. Cost-effectiveness of PST for primary care patients 
with mental health problems
Chapter 6 evaluates the costs of PST compared to UC after nine months, 
and resource use was measured from a social perspective using a validated 
questionnaire. Bootstrapping was used to analyse costs and cost-effectiveness 
of PST compared with UC. 
No significant statistical differences in clinical outcomes were found at 9 
months. Mean total costs were €4200 in the PST group and €7105 in the 
UC group. Despite this cost difference (€2905), costs were not significantly 
different between the two groups (95% CI -5652;35). Cost-effective analyses 
confirmed no difference in clinical effects and a tendency towards lower costs 
in the PST group. After multiple imputations this difference disappeared and 
PST was shown not to be cost-effective in comparison with UC in this study. It 
is recommended that future research should focus on specific patient groups, 
for example depressed patients or patients who do not recover or deteriorate 
after a period of continual study.
Chapter 7. General discussion
In the final chapter, the main objectives are addressed, primarily determining 
the effectiveness and cost-effectiveness of primary care PST for patients with 
mental health problems who visit the general practitioner (GP). 
Issues that have been raised in previous chapters are discussed, beginning 
with an overview of the main findings, followed by considerations for 
research methodology of this thesis, and results of the trial in light of earlier 
research. Recommendations for future research and general practice are then 
outlined, followed by a main conclusion. 
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Probleem oplossende behandeling (PST) uitgevoerd door verpleegkundigen 
in de huisartspraktijk voor patiënten met psychische klachten. 
Hoofdstuk 1. Introductie
De algemene introductie beschrijft en definieert kort de problemen met de 
geestelijke gezondheidszorg  in de huisartspraktijk, en de geschiedenis van 
de interventie (inclusief voorgaand onderzoek). Het doel en de opzet van 
dit proefschrift worden besproken, tezamen met de doelstelling van het 
onderzoek. Er is een voorbeeld ingevoegd om te situatie van patiënten met 
psychische klachten en de moeilijkheden die huisartsen ervaren met deze 
patiënten, te verduidelijken. 
Hoofdstuk 2. De onderzoeksopzet
In dit hoofdstuk wordt de onderzoeksopzet beschreven. De opzet behelst een 
onderzoek waarbij de patiënten ‘ blind’  zijn ingedeeld in de twee groepen 
door een externe onderzoeker (gerandomiseerd) en waarbij de behandeling 
vergeleken is met een controle groep (gecontroleerd). Het onderzoek is 
opgezet om te bekijken of deze behandeling (PST) beter helpt dan de 
gebruikelijke zorg (van de huisarts) en wat de kosten van deze behandeling 
zijn in vergelijking met de gebruikelijke zorg.  De patiënten die meegewerkt 
hebben aan ons onderzoek waren tenminste 18 jaar oud; hadden psychische 
klachten; en hebben vragenlijsten ingevuld voordat de behandeling van start 
ging, vlak na de behandeling (dat is ongeveer drie maanden later) en nog 
eens na negen maanden.
De belangrijkste uitkomstmaat in ons onderzoek is de afname van angst en 
depressie. Andere uitkomstmaten zijn: meer vaardigheden om problemen op 
te kunnen lossen, psychologisch en lichamelijk welzijn, dagelijks functioneren, 
sociale steun, gebruikte stijlen om met problemen om te gaan, de ervaren ernst 
van de problemen en gebruik van gezondheidszorg in het algemeen. 
De gebruikelijke zorg bestaat meestal uit medicatie of gesprekken. Verschillende 
onderzoeken uit Groot-Brittannië en de Verenigde Staten waarin PST gebruikt 
is in de huisartsenpraktijk worden besproken. Uit deze onderzoeken lijkt PST 
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een goede manier om met psychische klachten om te gaan en een aanwinst 
voor de huisartsenpraktijk. Op dat moment was er nog geen onderzoek in 
Nederland beschikbaar. 
Hoofdstuk 3. De uitkomsten na drie maanden
In dit hoofdstuk worden de uitkomsten van de verschillende metingen die 
gedaan zijn na drie maanden, besproken. Tevens worden de belangrijkste 
resultaten van de voormeting gepresenteerd. De verschillen tussen de behandelde 
groepen (PST en gebruikelijke zorg) zijn bekeken door gebruikmaking van 
statistische toetsen om het gemiddelde te vergelijken (de zgn. T-toets) en naar 
de verschillen tussen de groepen door de tijd heen (univariate GLM, regressie). 
Om heel precies naar het effect van de interventie te kunnen kijken hebben 
we gecorrigeerd voor de voormeting (covariaat). De patiënten die PST hadden 
gehad en die symptomen van depressie hadden zijn verbeterd, maar dit geldt 
ook voor mensen die gebruikelijke zorg van de huisarts kregen. Ditzelfde geldt 
voor patiënten met angstklachten, beide groepen blijken verbeterd. Nadat 
er gecorrigeerd is voor de voormeting, blijkt dit geen statistisch significante 
verbetering te zijn. We hebben daarom ook geconcludeerd dat PST gegeven 
door verpleegkundigen weinig toevoegt aan de gebruikelijke zorg die de 
huisarts al geeft aan mensen met psychische klachten. Een extra analyse 
achteraf laat zien dat het wel zo zou kunnen zijn dat er groep patiënten is die 
meer profijt van PST kan hebben, nl. degenen die hele ernstige depressieve 
klachten hebben.
Hoofdstuk 4. Uitkomsten na negen maanden en voorspellers van 
verbetering
De resultaten na negen maanden zijn geanalyseerd door de uitvoering van 
statische toetsen, waarbij de gegevens gebruikt zijn van de patiënten die de 
voormeting en de negen-maands meting (vervolgmeting) allebei hebben 
ingevuld. Er zijn geen statistisch significante verschillen gevonden tussen de 
groepen, maar we zien wel weer verbetering bij patiënten met depressieve 
klachten en bij patiënten met angstklachten in beide groepen. Dit geldt ook 
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voor het algemene psychologische welzijn; ook daar zien we een verbetering 
voor beide groepen. Toch zijn er ook wel wat verschillen in de uitkomsten 
tussen de groepen. De groep die de gebruikelijke zorg ontving verbeterde 
meer in algemeen fysiek welzijn en de groep die PST ontving, verbeterde in 
probleem-oplossende vaardigheden. 
De resultaten van de nameting suggereerden dat een hele ernstige depressieve 
groep patiënten meer baat zou kunnen hebben bij PST, maar na negen 
maanden is deze suggestie niet meer terug te vinden in de data. 
We hebben ook bestudeerd wat zou kunnen bepalen wanneer een patiënt 
herstelt van psychische klachten.  Om dit te doen hebben we eerst variabelen 
aangewezen als voorspellers. Vervolgens hebben we de samenhang bekeken 
tussen deze voorspellers en de uitkomst (verbetering). Er is maar 1 voorspeller 
die genoeg samenhangt met de uitkomst om van betekenis te kunnen zijn en 
dat is leeftijd. Wanneer iemand jonger is dan 50 is de kans op herstel groter. 
Er zijn geen andere voorspellers gevonden.
Concluderend kunnen we nu stellen dat we geen overtuigend bewijs hebben 
kunnen vinden dat PST op de lange termijn (negen maanden) huisartspatienten 
helpt om van psychische klachten te herstellen. De gebruikelijke zorg zoals 
de huisarts deze geeft hoeft niet vervangen te worden door PST.
Hoofdstuk 5. Vergelijking van instrumenten om psychologische 
behandelingen in de eerste lijns gezondheidszorg te evalueren
In ons onderzoek zijn verschillende instrumenten gebruikt om het effect van 
de behandeling te meten. Twee daarvan zijn met elkaar vergeleken: een lijst 
die depressie- en angstklachten meet (HADS) en een lijst waarin patiënten 
zelf invullen waar ze last van hebben (PSYCHLOPS). Om de sensitiviteit van 
deze lijsten met elkaar te vergelijken, zijn de effecten berekend en met elkaar 
vergeleken. De antwoorden op de PSYCHLOPS zijn ook nog geclassificeerd 
volgens een huisartsen systeem (ICPC) om in kaart te brengen hoe patiënten hun 
klachten verwoorden en of dit gelijk is aan klachten van depressie en angst. 
We hebben berekend dat de PSYCHLOPS een hoger effect heeft dan de HADS. 
Daarnaast blijkt dat patiënten voornamelijk problemen rapporteren over relaties 
en werk. Depressie- en angstklachten zijn veel minder vaak opgeschreven. 
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We hebben dan ook geconcludeerd dat de PSYCHLOPS wellicht beter in de 
praktijk past dan de HADS, en dat de PSYCHLOPS beter verandering (effect) 
kan laten zien. In onderzoek kan een conventionele maat als de HADS het 
gemeten effect van interventies onderschatten. 
Hoofdstuk 6. De kosten in vergelijking met de effectiviteit van 
PST voor huisartspatienten met psychische klachten
In dit hoofdstuk worden de kosten van PST berekend en vergeleken met de 
kosten van de gebruikelijke zorg, na negen maanden. We hebben naar alle 
maatschappelijke kosten gekeken en een gevalideerde (geldige) vragenlijst 
gebruikt. Om de (niet normaal verdeelde) kosten te analyseren is gebruik 
gemaakt van een statistisch hulpmiddel: ‘bootstrapping’. Er zijn geen significante 
statistische verschillen gevonden na negen maanden. Het gemiddelde van de 
totale kosten in de PST groep was lager dan in de groep die de gebruikelijke 
zorg ontving. Dit verschil is niet statistisch significant. Deze analyse bevestigt 
het gebrek aan verschil tussen de groepen in klinisch effect (afname van 
klachten) en laat zien dat er een tendens is dat mensen in de PST groep minder 
kosten maken. Nadat er gebruik is gemaakt van een gebruikelijk hulpmiddel 
‘multiple imputations’ (waarmee de missende data wordt aangevuld), blijkt 
dat het verschil kosten ook verdwijnt en dat PST dus niet goedkoper is dan de 
gebruikelijke zorg. Er wordt aanbevolen om  toekomstig onderzoek  te richten 
op specifieke patiënt groepen, zoals bijv. patiënten die heel ernstig depressief 
zijn of patiënten die niet verbeteren of patiënten die  verslechteren, ondanks 
de gebruikelijke zorg.
Hoofdstuk 7. Algemene discussie
In het laatste hoofdstuk worden de belangrijkste vraagstellingen beantwoord 
en de doelstelling besproken. Deze gaan over de effectiviteit en de kosten-
effectiviteit van de behandeling die we onderzocht hebben. In de voorafgaande 
hoofdstukken zijn er onderwerpen aan bod gekomen, die hier besproken 
worden,  Het begint met een overzicht van de belangrijkste bevindingen, 
gevolgd door overwegingen over de gebruikte methoden, en de resultaten 
Schreuders_v5.indd   119 19-07-2007   08:31:27
Samenvatting
120
van dit onderzoek in het licht van eerder onderzoek. Tenslotte worden er 
aanbevelingen gedaan voor vervolg onderzoek en voor de huisartspraktijk, 
gevolgd door een algemene conclusie.
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Appendix
Deel 1: Vertaalde PSYCHLOPS deel 1 en deel 2
(zie hoofdstuk 5)
Deel 2: Vertaalde PHQ (zie hoofdstuk 2)
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Een vragenlijst over u en hoe u zich voelt.
Vraag 1. Deze vraag bestaat uit drie delen: a-probleem, b- score en c-tijd
a Kies het probleem waarover u zich op dit moment het meeste zorgen maakt.
Schrijf dit a.u.b. op in onderstaand vak.
b Geef hieronder aan hoeveel dit probleem u heeft beïnvloed in de afgelopen week.
Omcirkel het juiste antwoord.
geheel niet heel erg
beïnvloed 0 1 2 3 4 5 beïnvloed
c Hoe lang geleden maakte u zich voor het eerst zorgen over dit probleem?
Kruis het hokje onder het juiste antwoord aan.
langer dan 3,
tussen 1-3 maar korter dan tussen 1-5 langer dan
1 maand maanden 12 maanden jaar 5 jaar
Vraag 2. Deze vraag bestaat uit drie delen: a-probleem, b- score en c-tijd
a Kies een ander probleem waar u zich zorgen over maakt.
Schrijf dit a.u.b. op in onderstaand vak.
b Geef hieronder aan hoeveel dit probleem u heeft beïnvloed in de afgelopen week.
Omcirkel het juiste antwoord.
geheel niet heel erg
bezig gehouden 0 1 2 3 4 5 beziggehouden
c Hoe lang geleden maakte u zich voor zorgen over dit probleem?
Kruis het hokje onder het juiste antwoord aan.
langer dan 3,
tussen 1-3 maar korter dan tussen 1-5 langer dan
1 maand maanden 12 maanden jaar 5 jaar
Vraag 3. Deze vraag bestaat uit twee delen: a-activiteit en b- score
a Kies één ding dat lastig is om uit te voeren vanwege uw problemen.
b Wilt u aangeven hoe lastig het was om deze activiteit uit te voeren in de afgelopen
week? Omcirkel het juiste getal
helemaal heel
niet lastig 0 1 2 3 4 5 lastig
Vraag 4. Deze vraag bestaat uit één gedeelte.
Hoe heeft u zich de afgelopen week gevoeld? Omcirkel het juiste getal
heel goed 0 1 2 3 4 5 heel slecht
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Een vragenlijst over u en hoe u zich voelt.
Vraag 1. Deze vraag bestaat uit drie delen: a-probleem, b- score en c-tijd
a Kies het probleem waarover u zich op dit moment het meeste zorgen maakt.
Schrijf dit a.u.b. op in onderstaand vak.
b Geef hieronder aan hoeveel dit probleem u heeft beïnvloed in de afgelopen week.
Omcirkel het juiste antwoord.
geheel niet heel erg
beïnvloed 0 1 2 3 4 5 beïnvloed
c Hoe lang geleden maakte u zich voor het eerst zorgen over dit probleem?
Kruis het hokje onder het juiste antwoord aan.
langer dan 3,
tussen 1-3 maar korter dan tussen 1-5 langer dan
1 maand maanden 12 maanden jaar 5 jaar
Vraag 2. Deze vraag bestaat uit drie delen: a-probleem, b- score en c-tijd
a Kies een ander probleem waar u zich zorgen over maakt.
Schrijf dit a.u.b. op in onderstaand vak.
b Geef hieronder aan hoeveel dit probleem u heeft beïnvloed in de afgelopen week.
Omcirkel het juiste antwoord.
geheel niet heel erg
bezig gehouden 0 1 2 3 4 5 beziggehouden
c Hoe lang geleden maakte u zich voor zorgen over dit probleem?
Kruis het hokje onder het juiste antwoord aan.
langer dan 3,
tussen 1-3 maar korter dan tussen 1-5 langer dan
1 maand maanden 12 maanden jaar 5 jaar
Vraag 3. Deze vraag bestaat uit twee delen: a-activiteit en b- score
a Kies één ding dat lastig is om uit te voeren vanwege uw problemen.
b Wilt u aangeven hoe lastig het was om deze activiteit uit te voeren in de afgelopen
week? Omcirkel het juiste getal
helemaal heel
niet lastig 0 1 2 3 4 5 lastig
Vraag 4. Deze vraag bestaat uit één gedeelte.
Hoe heeft u zich de afgelopen week gevoeld? Omcirkel het juiste getal
heel goed 0 1 2 3 4 5 heel slecht
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Een vervolg-vragenlijst over u en hoe u zich voelt.
Vraag 1. Deze vraag bestaat uit twee delen: a-probleem en b- score
a Dit is het probleem waarvan u twee maanden geleden zei dat u zich daar het meeste zorgen
over maakte.
b Geef hieronder aan hoeveel dit probleem u heeft beïnvloed in de afgelopen week.
Omcirkel het juiste antwoord.
geheel niet heel erg
beïnvloed 0 1 2 3 4 5 beïnvloed
Vraag 2. Deze vraag bestaat uit twee delen: a-probleem en b- score
a Dit is het andere probleem waarvan u twee maanden geleden zei dat u zich daar zorgen over
maakte.
b Geef hieronder aan hoeveel dit probleem u heeft beïnvloed in de afgelopen week.
Omcirkel het juiste antwoord.
geheel niet heel erg
bezig gehouden 0 1 2 3 4 5 beziggehouden
Vraag 3. Deze vraag bestaat uit twee delen: a-activiteit en b- score
a Dit is de activiteit waarvan u ongeveer twee maanden geleden zei dat dit lastig was om te
doen.
b Geef hieronder aan hoe lastig het was om deze activiteit te doen in de afgelopen
week. Omcirkel het juiste getal
helemaal heel
niet lastig 0 1 2 3 4 5 lastig
Vraag 4. Deze vraag bestaat uit één gedeelte.
Hoe heeft u zich de afgelopen week gevoeld? Omcirkel het juiste getal
heel goed 0 1 2 3 4 5 heel slecht
Vraag 5. Deze vraag bestaat uit twee delen: a-probleem en b- score.
a Is er een nieuw probleem opgetreden in de afgelopen twee maanden?
Indien dit zo is, schrijf dit a.u.b. op in onderstaand vak.
b Geef hieronder aan hoeveel dit probleem u heeft beïnvloed in de afgelopen week.
Omcirkel het juiste antwoord.
geheel niet heel erg
beïnvloed 0 1 2 3 4 5 beïnvloed
P H Q
Patient Health Questionnaire
Door middel van deze vragenlijst wordt inzicht verkregen in uw gezondheidstoestand.
Wilt u elke vraag beantwoorden door het juiste hokje aan te kruisen? Vul de lijst volledig in.
Wanneer u twijfelt over het antwoord op een vraag, probeer dan het antwoord te geven dat
het meest van toepassing is.
Naam_______________________ Leeftijd ________ Geslacht: Vrouw Man Datum___________
1.   Hoeveel last heeft u in de afgelopen 4 weken gehad van
een van de volgende problemen?
geen last een beetje last veel last
a. Maagpijn   
b. Rugpijn   
c. Pijn in armen, benen, gewrichten (bijv. knieën,
heupen)
  
d. Pijn of problemen bij de menstruatie   
e. Pijn of problemen bij de geslachtsgemeenschap   
f. Hoofdpijn   
g. Pijn op de borst   
h. Duizeligheid   
i. Neiging tot flauwvallen, flauwtes   
j. Hartkloppingen   
k. Kortademigheid   
l. Verstopping, dunne ontlasting, diarree   
m. Misselijkheid, winderigheid, opgeblazen gevoel   
2. Hoe vaak heeft u in de afgelopen 2 weken last gehad van
een van de volgende problemen? Helemaal
niet
Enkele
dagen
Meer dan
de helft
van de
dagen
Bijna elke
dag
a. Weinig zin of plezier om iets te doen    
b. Somberheid, neerslachtigheid, ’t niet zien zitten    
c. Moeite met inslapen of doorslapen of teveel slapen    
d. Vermoeidheid, weinig energie    
e. Weinig trek in eten of teveel eten    
f. Bent u ontevreden over uzelf of heeft u het gevoel dat u
een mislukking bent of dat u tekortschiet voor uzelf of
uw naasten?
   
g. Heeft u moeite om u te concentreren op iets, bijv. bij het
lezen van de krant of bij het televisie kijken?    
h. Beweegt of spreekt u zo traag dat het anderen zou
kunnen opvallen? En hoe is het met het
tegenovergestelde? Voelt u zich zo gespannen dat u veel
rustelozer bent dan gewoonlijk?    
i. Heeft u wel eens gedacht dat u beter dood kon zijn of
hebt u eraan gedacht uzelf te verwonden?    
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Een vervolg-vragenlijst over u en hoe u zich voelt.
Vraag 1. Deze vraag bestaat uit twee delen: a-probleem en b- score
a Dit is het probleem waarvan u twee maanden geleden zei dat u zich daar het meeste zorgen
over maakte.
b Geef hieronder aan hoeveel dit probleem u heeft beïnvloed in de afgelopen week.
Omcirkel het juiste antwoord.
geheel niet heel erg
beïnvloed 0 1 2 3 4 5 beïnvloed
Vraag 2. Deze vraag bestaat uit twee delen: a-probleem en b- score
a Dit is het andere probleem waarvan u twee maanden geleden zei dat u zich daar zorgen over
maakte.
b Geef hieronder aan hoeveel dit probleem u heeft beïnvloed in de afgelopen week.
Omcirkel het juiste antwoord.
geheel niet heel erg
bezig gehouden 0 1 2 3 4 5 beziggehouden
Vraag 3. Deze vraag bestaat uit twee delen: a-activiteit en b- score
a Dit is de activiteit waarvan u ongeveer twee maanden geleden zei dat dit lastig was om te
doen.
b Geef hieronder aan hoe lastig het was om deze activiteit te doen in de afgelopen
week. Omcirkel het juiste getal
helemaal heel
niet lastig 0 1 2 3 4 5 lastig
Vraag 4. Deze vraag bestaat uit één gedeelte.
Hoe heeft u zich de afgelopen week gevoeld? Omcirkel het juiste getal
heel goed 0 1 2 3 4 5 heel slecht
Vraag 5. Deze vraag bestaat uit twee delen: a-probleem en b- score.
a Is er een nieuw probleem opgetreden in de afgelopen twee maanden?
Indien dit zo is, schrijf dit a.u.b. op in onderstaand vak.
b Geef hieronder aan hoeveel dit probleem u heeft beïnvloed in de afgelopen week.
Omcirkel het juiste antwoord.
geheel niet heel erg
beïnvloed 0 1 2 3 4 5 beïnvloed
P H Q
Patient Health Questionnaire
Door middel van deze vragenlijst wordt inzicht verkregen in uw gezondheidstoestand.
Wilt u elke vraag beantwoorden door het juiste hokje aan te kruisen? Vul de lijst volledig in.
Wanneer u twijfelt over het antwoord op een vraag, probeer dan het antwoord te geven dat
het meest van toepassing is.
Naam_______________________ Leeftijd ________ Geslacht: Vrouw Man Datum___________
1.   Hoeveel last heeft u in de afgelopen 4 weken gehad van
een van de volgende problemen?
geen last een beetje last veel last
a. Maagpijn   
b. Rugpijn   
c. Pijn in armen, benen, gewrichten (bijv. knieën,
heupen)
  
d. Pijn of problemen bij de menstruatie   
e. Pijn of problemen bij de geslachtsgemeenschap   
f. Hoofdpijn   
g. Pijn op de borst   
h. Duizeligheid   
i. Neiging tot flauwvallen, flauwtes   
j. Hartkloppingen   
k. Kortademigheid   
l. Verstopping, dunne ontlasting, diarree   
m. Misselijkheid, winderigheid, opgeblazen gevoel   
2. Hoe vaak heeft u in de afgelopen 2 weken last gehad van
een van de volgende problemen? Helemaal
niet
Enkele
dagen
Meer dan
de helft
van de
dagen
Bijna elke
dag
a. Weinig zin of plezier om iets te doen    
b. Somberheid, neerslachtigheid, ’t niet zien zitten    
c. Moeite met inslapen of doorslapen of teveel slapen    
d. Vermoeidheid, weinig energie    
e. Weinig trek in eten of teveel eten    
f. Bent u ontevreden over uzelf of heeft u het gevoel dat u
een mislukking bent of dat u tekortschiet voor uzelf of
uw naasten?
   
g. Heeft u moeite om u te concentreren op iets, bijv. bij het
lezen van de krant of bij het televisie kijken?    
h. Beweegt of spreekt u zo traag dat het anderen zou
kunnen opvallen? En hoe is het met het
tegenovergestelde? Voelt u zich zo gespannen dat u veel
rustelozer bent dan gewoonlijk?    
i. Heeft u wel eens gedacht dat u beter dood kon zijn of
hebt u eraan gedacht uzelf te verwonden?    
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3. Vragen over angst.
a. Heeft u in de laatste 4 weken een angstaanval gehad –
plotseling angst of paniek voelen?
 Indien u ‘nee’ hebt ingevuld, ga naar vraag 5.
 Indien u ‘ja’ hebt ingevuld, ga hier verder.
Nee

Ja

b. Heeft u dit ooit eerder meegemaakt?  
c. Treedt de aanval soms volkomen onverwachts op – dat wil
zeggen in situaties waarvan u niet verwacht dat u zich er
nerveus of ongemakkelijk in voelt?  
d. Zit u er erg over in dat een nieuwe aanval kan optreden of
dat er iets met u mis is?  
4.  Neem uw laatste heel hevige aanval nu in gedachten. Nee Ja
a. Voelde u zich kortademig?  
b. Voelde u uw hart kloppen, bonzen, of een slag overslaan?  
c. Had u last van pijn of een drukkend gevoel op de borst?  
d. Transpireerde u?  
e. Had u het gevoel te zullen stikken?  
f. Brak het zweet uit of had u last van koude rillingen?  
g. Voelde u zich misselijk, had u last van uw maag of had u
het gevoel diarree te zullen krijgen?  
h. Voelde u zich duizelig, zweverig of had u het gevoel te
zullen flauwvallen?
 
i. Had u last van tintelingen of een doof gevoel op bepaalde
plaatsen in uw lichaam?
 
j. Trilde of beefde u?  
k. Was u bang dood te zullen gaan?  
5. Hoe vaak heeft u de afgelopen 4 weken last gehad van een
van de volgende problemen?
Helemaal
niet
Enkele
dagen
Meer dan de
helft van de
dagen
a. Heeft u zich nerveus, angstig of gespannen gevoeld?
Indien u ‘helemaal niet’ heeft ingevuld, ga naar vraag 6.
Indien u ‘enkele dagen’ of ‘meer dan de helft’ heeft ingevuld,
ga hier verder.
  
b. U zo rusteloos voelen dat u moeilijk stil kon zitten?   
c. Zeer snel vermoeid raken?   
d. Gespannen spieren, pijn of gevoelige plekken?   
e. Moeite hebben met inslapen of doorslapen?   
f. Moeite met concentratie, zoals bij het lezen van een
boek of bij het televisie kijken?   
g. Gemakkelijk geërgerd of geïrriteerd raken?   
P H Q
6. Vragen over eten.
a. Hebt u vaak het gevoel dat u geen controle hebt over wat
of hoeveel u eet?
Nee

Ja

b. Komt het vaak voor dat u – in twee uur – hoeveelheden
voedsel eet die de meeste mensen als ongebruikelijk veel
zouden beschouwen?
 Indien u ‘nee’ hebt ingevuld bij ofwel a. of b. ga dan naar vraag 9.
 
c. Is dit gemiddeld twee keer per week – in de afgelopen 3
maanden – voorgekomen?  
7.  Hebt u gedurende de afgelopen 3 maanden vaak een van de
volgende dingen gedaan om gewichtstoename te voorkomen? Nee Ja
a. Gezorgd dat u moest overgeven?  
b. Meer dan twee keer de hoeveelheid voorgeschreven
laxeermiddelen genomen?
 
c. Gevast – Helemaal niets gegeten gedurende minstens 24
uur?
 
d. Meer dan een uur lang getraind om te voorkomen dat u in
gewicht aankomt door vreetbuien?  
8.  Indien u ‘ja’ hebt ingevuld bij een of meer van deze manieren
om gewichtstoename te voorkomen: is dit gemiddeld tweemaal
per week of vaker voorgekomen?
Nee

Ja

9. Drinkt u ooit alcohol (inclusief bier of wijn)?
Indien u ‘nee’ hebt ingevuld, ga naar vraag 11.
Nee

Ja

10. Is een van de volgende gebeurtenissen u meer dan eens in de
afgelopen 6 maanden overkomen? Nee Ja
a. Dronk u alcohol ondanks dat een arts u heeft aangeraden
te stoppen met drinken vanwege een probleem met uw
gezondheid?
 
b. Dronk u, was u dronken, of had u een kater in werktijd,
bij het naar school gaan of bij het vervullen van andere
taken?
 
c. Heeft u uw werk verzuimd of kwam u te laat – op uw werk
of op school of bij het vervullen van andere taken –
vanwege uw drinkgedrag of uw kater?
 
d. Heeft u problemen ervaren in de omgang met anderen als u
aan het drinken bent?  
e. Rijdt u auto nadat u verschillende glazen heeft gedronken
of teveel heeft gedronken?  
11. Indien u een  van deze problemen hebt aangekruist: hoe moeilijk was het voor u om
door deze problemen uw werk te doen, voor uw zaken thuis te zorgen, of om te gaan
met andere mensen?
Helemaal niet moeilijk Enigszins moeilijk Erg moeilijk Extreem moeilijk
   
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6. Vragen over eten.
a. Hebt u vaak het gevoel dat u geen controle hebt over wat
of hoeveel u eet?
Nee

Ja

b. Komt het vaak voor dat u – in twee uur – hoeveelheden
voedsel eet die de meeste mensen als ongebruikelijk veel
zouden beschouwen?
 Indien u ‘nee’ hebt ingevuld bij ofwel a. of b. ga dan naar vraag 9.
 
c. Is dit gemiddeld twee keer per week – in de afgelopen 3
maanden – voorgekomen?  
7.  Hebt u gedurende de afgelopen 3 maanden vaak een van de
volgende dingen gedaan om gewichtstoename te voorkomen? Nee Ja
a. Gezorgd dat u moest overgeven?  
b. Meer dan twee keer de hoeveelheid voorgeschreven
laxeermiddelen genomen?
 
c. Gevast – Helemaal niets gegeten gedurende minstens 24
uur?
 
d. Meer dan een uur lang getraind om te voorkomen dat u in
gewicht aankomt door vreetbuien?  
8.  Indien u ‘ja’ hebt ingevuld bij een of meer van deze manieren
om gewichtstoename te voorkomen: is dit gemiddeld tweemaal
per week of vaker voorgekomen?
Nee

Ja

9. Drinkt u ooit alcohol (inclusief bier of wijn)?
Indien u ‘nee’ hebt ingevuld, ga naar vraag 11.
Nee

Ja

10. Is een van de volgende gebeurtenissen u meer dan eens in de
afgelopen 6 maanden overkomen? Nee Ja
a. Dronk u alcohol ondanks dat een arts u heeft aangeraden
te stoppen met drinken vanwege een probleem met uw
gezondheid?
 
b. Dronk u, was u dronken, of had u een kater in werktijd,
bij het naar school gaan of bij het vervullen van andere
taken?
 
c. Heeft u uw werk verzuimd of kwam u te laat – op uw werk
of op school of bij het vervullen van andere taken –
vanwege uw drinkgedrag of uw kater?
 
d. Heeft u problemen ervaren in de omgang met anderen als u
aan het drinken bent?  
e. Rijdt u auto nadat u verschillende glazen heeft gedronken
of teveel heeft gedronken?  
11. Indien u een  van deze problemen hebt aangekruist: hoe moeilijk was het voor u om
door deze problemen uw werk te doen, voor uw zaken thuis te zorgen, of om te gaan
met andere mensen?
Helemaal niet moeilijk Enigszins moeilijk Erg moeilijk Extreem moeilijk
   
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12. Hoeveel last heeft u in de afgelopen 4 weken gehad van
een van de volgende problemen?
Geen last Weinig last Veel last
a. Zorgen over uw gezondheid   
b. Uw gewicht of hoe u eruit ziet   
c. Weinig of geen zin in seks of geen plezier tijdens
geslachtsgemeenschap
  
d. Problemen met echtgenoot/echtgenote, partner of
vriend/vriendin   
e. Spanning of stress van de zorg voor kinderen, ouders of
andere familieleden   
f. Spanning of stress op het werk buitenshuis of op school   
g. Financiële problemen of zorgen   
h. Niemand hebben bij wie u terecht kunt als u een probleem
heeft
  
i. Iets vervelends dat onlangs gebeurd is   
j. Denken of dromen over iets verschrikkelijks dat u in het
verleden overkwam – zoals bijv. het verwoesten van uw
huis, een ernstig ongeluk, geslagen of aangevallen zijn, of
gedwongen zijn tot seks.   
13. Bent u in het afgelopen jaar geslagen, geschopt of anderszins fysiek pijn
gedaan door iemand, of heeft iemand u gedwongen tot ongewilde seksuele
handelingen?
Nee

Ja

14. Wat levert u op dit moment de meeste stress of spanning in uw leven op? ……………………………….
      …………………………………………………………………………………………………………………………………………………………
15. Gebruikt u medicatie voor angst, depressie, spanning of stress? Nee

Ja

16. ALLEEN VOOR VROUWEN: vragen over menstruatie, zwangerschap en bevalling.
a. Wat is de beste beschrijving van uw menstruaties?
Menstruaties
zijn
ongewijzigd

Geen
menstruaties
vanwege
zwangerschap of
recente bevalling

Menstruaties zijn
onregelmatig
geworden of
veranderd in
frequentie, duur of
hoeveelheid

Meer dan een
jaar geen
menstruaties
gehad

Menstruaties bij gebruik
van hormoontherapie
(oestrogenen) of orale
anticonceptiva (‘de pil’)

b. Hebt u in de week voordat uw menstruatie start erg veel last van
uw stemming – zoals depressie, angst, snel geïrriteerd zijn,
boosheid, of stemmingswisselingen?
Nee
(of niet van
toepassing)

Ja

c. Indien Ja: verdwijnen deze problemen aan het eind van de
menstruatie?
 
d. Bent u in de afgelopen 6 maanden bevallen?  
e. Hebt u in de afgelopen 6 maanden een miskraam gehad?  
f. Hebt u op dit moment problemen om zwanger te raken?  
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